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Abstract 
    Bacterial antimicrobial resistance represents an important current and future problem in 
infectious disease public health. When reviewing longitudinal studies (research studies 
involving repeated observations of a location over a period of time), very little information 
was found regarding the proliferation and dissemination of foodborne bacteria in a new dairy 
farm environment. Iowa State University (ISU; Ames IA) was awarded 887 acres of land by 
a donor family. An academic teaching farm was later constructed, The Dairy/Animal Science 
Education Facility (or the ISU Dairy Farm). Prior to building the ISU Dairy Farm, the land 
was only used for recreational activities-no production livestock had ever been introduced. It 
was decided to study the bacteria microbiota Enterobacteriaceae (particularly Salmonella), 
Enterococcus and Campylobacter. Microbiological sampling was conducted using a variety 
of techniques-from phenotypic methods (e.g. detecting bacteria by using specialized media) 
to genotypic methods (e.g. Pulsed Field Gel Electrophoresis). Sampling took place prior to 
dairy cattle placement (20 October 2007 and 13 November 2007) and after placement (27 
January 2008, 29 February 2008, 12 March 2008, 23 April 2008 and 28 May 2008). A 
literature review discussing the introduction of dairy cattle to the United States, antibiotics 
used in animal production, antibiotic resistance, and the “prudent” (or responsible) use of 
antibiotics is discussed in chapter 1.  Data from the ISU Dairy Farm Studies are included in 
chapter 2 (the establishment and proliferation of antibiotic-resistant Campylobacter), chapter 
3 (the establishment and proliferation of Enterococcus spp.) and chapter 4 (the establishment 
of Enterobacteriaceae and Salmonella london). Chapter 5 addresses general conclusions of 
this work and recommendations for future research.
 1
 
Introduction 
    Dairy cows were first brought to the United States in the 1600s (17) and the dairy industry 
has changed much since then. In 2006, a total of 9.1 million cows were on 2 million farms-a 
considerable change from over 21 million cows on 5 million farms in 1910 (21). The rapid 
progress in genetics and management has created a new era in which a smaller number of 
dairy cows meet the growing demand for dairy products (27). Since 1970, milk production 
has risen by almost half, even though the numbers of dairy cows have declined by about a 
fourth (from about 12 million in 1970 to about 9.1 million in 2006) (22). The growth of 
animals in conditions of crowding often favors the appearance of infectious disease that 
require antimicrobial treatment (14) often at great expense to the dairy producer. Mastitis is 
the costliest disease in the dairy industry, generating losses of over $ 2 billion in the US alone 
(18).  
    There is controversy regarding the use of antibiotics in growth promotion and prophylaxis 
in agriculture. Some researchers believe that the use of antibiotics is implicated as a 
contributing source of resistant bacterial strains that can be transmitted to humans through 
the food chain (3, 4). Others feel that commercial livestock production in the US (especially 
confinement production) would be virtually impossible without antibiotics (11). To support 
this view they cite studies such as those demonstrating that low levels of antimicrobial drugs 
increase daily rates of weight gain and improve feed efficiency in livestock (which lowers 
feed costs) (11). Additionally, weight gain ranging from 4-60 percent has been observed in 
animals fed low levels of antibiotics (8, 11). In the last 25 years however, there has been a 
paradigm shift from the treatment of clinical illness to disease prevention using techniques 
such as epidemiology (to describe and quantify the interconnected risk factors that produce 
disease), redefining disease more broadly (to include subclinical conditions such subclinical 
mastitis, ketosis and rumen acidosis), and improving the understanding of the metabolism 
and physiology of cows (10).  Scientists are also addressing concerns about animal welfare 
and researching topics such as animal comfort and the physical and mental well-being of 
animals (25). It is hoped that these activities can contribute to the responsible use of 
antibiotics.  Milk has a positive reputation of being a wholesome and health-promoting food, 
and most dairy farms are independent family farms where cows are well-cared for (27). 
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However, if consumers perceive milk to be unsafe for zoonotic reasons, or disapprove of 
animal husbandry practices, they can respond by consuming less dairy products (5, 27). 
    The World Health Organization (WHO) estimates that 1.5 million people died worldwide 
from diarrheal diseases in 2005 (2). A separate study estimates that 70% of diarrheal diseases 
are foodborne (2). Collectively, foodborne diseases incur enormous financial costs. In the 
US, the estimated financial costs for six bacterial pathogens (Campylobacter jejuni, 
Clostridium perfringes, Escherichia coli O157:H7, Listeria monocytogenes, Salmonella, 
Staphylococcus aureus) and 1 parasite (Toxoplasma gondii) were estimated at $6.5 billion to 
$34.9 billion dollars annually (1, 2). This is likely an underestimate of total foodborne 
diseases costs because there may be over 200 microbiologic agents that cause foodborne 
disease (2).   
    Salmonella infections are among the most prevalent recognized communicable disease 
cause by bacteria in the US (13). The vast majority of these infections are transmitted from 
animals to humans through food and occasionally from person to person by the fecal-oral 
route (13). Salmonella serotypes enteritidis, typhimurium, and newport accounted for 43% of 
isolates from human sources reported to the US Centers for Disease Control and Prevention 
(CDC) (23). Salmonella contamination is most frequently associated with eggs and poultry 
products, but milk and dairy products have also been implicated (23). Dairy-related 
foodborne outbreaks of Salmonella have been associated with consumption of unpasteurized 
milk as well as milk products contaminated post-processing (23). Ground beef has also been 
implicated in outbreaks (23).  
    Enterococcus spp. are a complex, diverse and important group of bacteria in terms of their 
interaction with humans and animals (7). They are ubiquitous and are found in the 
gastrointestinal tracts of humans and other animals, in soil, water, and in the foods we eat (7). 
For many years, Enterococcus were believed to be harmless to humans and considered 
unimportant medically (6). Recently, enterococci have become one of the most common 
hospital-acquired pathogens, with patients having a high mortality rate of up to 61% (6). 
Enterococcus also cause infections in animals including mastitis in cattle, diarrhea in animals 
such as calves and foals, as well as infections in birds (7). Enterococci are resistant to many 
antibiotics. In an increasing number of cases, vancomycin is the only drug that remains 
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effective. The emergence of vancomycin-resistant Enterococcus (VRE) is of particular 
concern (26).  
    Campylobacter is the most commonly isolated bacterial enteric pathogen of humans in the 
US, exceeding Salmonella (27). Until recently, little attention was paid to Campylobacter 
because their role as enteric pathogens were not discovered until the late 1970s (20). In 
addition, infection is rarely fatal and they seldom cause large outbreaks (20). The infectious 
dose is extremely low (about 500 organisms) and can cause a range of disease from acute 
diarrhea to abortion in sheep, cattle and (rarely) humans (16). In one out of 3000 cases of 
human campylobacteriosis, post-infection manifestations can result-including Guillain-Barré  
syndrome (ascending paralysis) and Miller-Fisher Syndrome (characterized by blurred vision 
and severe lack of muscle coordination) (15). Campylobacters are considered to be a part of 
the normal flora of a wide range of domestic and wild animals (24). They are widespread in 
the environment, where their presence suggests recent contamination with animal and avian 
species, agricultural runoff, and sewage effluent (9). Campylobacters are often isolated from 
cattle and sheep, however shedding in feces is intermittent (9, 24). Factors which encourage 
fecal shedding of Campylobacter include giving birth, weaning, change of pasture, 
movement outdoors and transport (9). 
    Bacterial antimicrobial resistance represents an important current and future problem in 
infectious disease public health (3). When reviewing longitudinal studies (a research study 
involving repeated observations of a location over a period of time) (19), very little 
information was found regarding the proliferation and dissemination of foodborne bacteria in 
a new dairy farm environment. Iowa State University (ISU; Ames IA) was awarded 887 
acres of land by a donor family. An academic teaching farm was constructed, The 
Dairy/Animal Science Education Facility (or the ISU Dairy Farm). Prior to building the ISU 
Dairy Farm, the land was only used for recreational activities-no livestock had ever been 
introduced. It was decided to study the bacteria microflora Enterobacteriaceae (particularly 
Salmonella), Enterococcus and Campylobacter. Microbiological sampling was conducted 
using a variety of techniques-from phenotypic (detecting bacteria by using specialized 
media) to genotypic methods (Pulsed Field Gel Electrophoresis). Sampling took place prior 
to dairy cattle placement (20 October 2007 and 13 November 2007) and after placement (27 
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January 2008, 29 February 2008, 12 March 2008, 23 April 2008 and 28 May 2008). Data 
from these studies are included in chapter 2 (the establishment and proliferation of antibiotic-
resistant Campylobacter), chapter 3 (the establishment and proliferation of Enterococcus 
spp.) and chapter 4 (the establishment of Enterobacteriaceae and Salmonella london). 
Chapter 5 addresses general conclusions of this work and recommendations for future 
research.  
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A determination of antibiotic resistance before and after the introduction of production 
livestock 
 
Literature Review 
 
    Dairy cattle were first brought to the United States in the 1600s (66). The dairy industry 
has changed considerably since then. In 1910, more than 20 million cows were maintained on 
5 million farms, averaging 4 cows per farm (64, 66). In 2006, a total of 9.1 million cows 
were on 2 million farms (64, 85).  Despite the overall decrease in the number of animals, 
production of dairy products has increased substantially. Milk production increased from 
66,464 million kg (146,528 million lb) in 1991 to 81,809 million kg (180,357 million lb) in 
2006 (85). Consumers drink an average of 104.5 kg (230 lb) of milk and eat approximately 
12 kg (26 lb) of cheese, 7.3 kg (16 lb) of ice cream and 2.3 kg (5 lb) of butter per capita 
annually (66). Mortality and morbidity among dairy cattle can result in increased health 
costs, reduced milk yield, and decreased profits for the producer. Additionally, milk can 
harbor a variety of microorganisms that can be an important source of foodborne pathogens 
(70). Foodborne diseases are estimated to cause an estimated 76 million human illnesses, 
325,000 hospitalizations, and 5,000 deaths in the United States yearly (38). 
    Vaccinations are a major means of controlling viral and bacterial infections in dairy herds. 
However diarrhea and respiratory disease are the most common illness among cattle (85). For 
example, clinical mastitis among US dairy cows increased from 14.7% in 2002 to 16.5 % in 
2008 (66). Antibiotics such as amoxicillin, erythromycin and oxytetracycline are used to treat 
intramammary infections (66). Antibiotics are defined as substances produced by fungi, 
bacteria (or by pharmaceutical chemists) that kill or inhibit the growth of other 
microorganisms without harm to the eukaryotic host (55, 76).They work by exploiting 
differences that exists in cell structure between bacterial (prokaryotic) cells and animal 
(eukaryotic) cells. Antibiotics are often described as “bacteriostatic” or “bactericidal” (74). 
The term bacteriostatic describes a drug that temporarily inhibits the growth of an organism. 
Once the drug is removed, the organism will resume growth. The term bactericidal refers to a 
drug that causes cell death (74). Bactericidal drugs are used extensively to prevent or treat 
microbial infections in human and veterinarian medicine (48). Antimicrobial agents have 
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been widely used in livestock and poultry since the 1950’s (56). Since then, food animal 
production includes larger farms and greater animal densities, requiring an increased need for 
disease management (56). According to the 2007 Census of Agriculture, the numbers of 
farms declined from 2.5 million to 2 million. However, during the same time period 
(according to NARMS) a, the average number of cattle on a dairy farm increased from 57.4 to 
219.7 animals (85).  
    In food animal production, antibiotics are used for 4 main purposes: therapeutic use to 
treat sick animals, metaphylaxis (group treatment), prevention of infections at times of risk 
(such as transport and weaning), and growth promotion (to improve feed utilization and 
production) (56, 58). Growth promotion is also referred to as “improved feed efficiency” in 
some literature (5, 86). Growth promoters allows farmers to increase the body weight of their 
animals without increasing the quantity of animal feed (68). It is uncertain if weight gain is 
due to prevention of infection or some other physiological effect (68). In the United States, 
an estimated 23 million kg  (51 million lb) of antibiotics are used annually; about half are 
provided for humans, and the remaining are manufactured for agriculture (50). About 7 
million kg (15.4 million lb) of antibiotics, chiefly penicillins and tetracyclines, are used as 
growth promoters for food animals (50). 
Tetracycline 
    Antibiotics are classified by chemical structure and mechanism of action (55). A detailed 
classification is beyond the scope of this review.  However, the antibiotics used in this work 
will be discussed. In 1944, Benjamin M. Duggar, a plant physiologist, discovered the first 
tetracycline (chlortetracycline) while studying soil samples for antimicrobial properties. It 
was introduced into clinical practice in 1948 (12, 74). Tetracyclines are classified as broad-
spectrum antibiotics. This group includes tetracycline, oxytetracycline, doxycycline and 
minocycline (76). Naturally occurring  
 
aNARMS is a collaboration of agencies including the Centers for Disease Control and Prevention (CDC), the 
Food and Drug Administration (FDA), the Center for Veterinary Medicine, United States Department of 
Agriculture (CVM-USDA) and state and local health departments (4). In addition to NARMS, the Foodborne 
Diseases Active Surveillance Network (FoodNet) conducts studies to estimate the burden and sources of 
specific food-borne diseases (4). 
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tetracyclines such as oxytetracycline are isolated from species of Streptomyces while other 
tetracycline “classes” such as glyclycyclines are semisynthetic (18, 73). The semisynthetic 
classes of tetracycline are noted for resisting stomach acid and are absorbed from the 
intestines after oral consumption (73).  Because of their slow excretion into urine, they are 
used to treat urinary tract infections. Amoxicillin has the added benefit of being acid-stable 
and does not bind to food as many antibiotics can (73). Structurally, tetracyclines are 
characterized by a hydronaphthacene nucleus with four fused rings (12, 55). Tetracyclines 
are relatively stable in acids but not in bases and form salts in both media (83).The 
tetracyclines are bacteriostatic or bactericidal depending on its affinity for a given target 
structure and its ability to cross the various structural barriers that bar access  (12).  
    The traditional tetracyclines (including tetracycline, doxycycline, and minocycline) inhibit 
protein synthesis at the ribosomal level due to disruption of codon-codon interactions 
between tRNA and mRNA (12). “Atypical” tetracyclines such as chelocardin and 
anhydrochlorotetracycline act on bacteria by interfering with the electrochemical gradient of 
the bacterial membrane (12). This promotes lysis and cell death by stimulating autolytic 
enzyme activity (12). The antibacterial spectrum and activity of tetracyclines include 
numerous Gram-positive and Gram-negative bacteria, anaerobes, rickettsiae, mycoplasmas, 
chlamydiae, Helicobacter pylori and spirochetes (12). Certain tetracyclines are also active 
against a number of mycobacteria (Mycobacterium leprae) and protozoa such as Plasmodium 
spp. and Toxoplasma gondii (12). Tetracyclines can be given orally, intramuscularly or 
intravenously (76). Adverse effects to tetracycline ingestion include gastrointestinal problems 
such as epigastric burning, nausea, vomiting, and anorexia (74). Food can be taken to 
alleviate some symptoms but may also decrease drug absorption by 50% (74). Other side 
effects include hypersensitivity reactions and hepatotoxicity-which can be fatal (74). 
    Tetracyclines are usually not recommended for children under 8 years of age because they 
can cause permanent discoloration of teeth, and bone growth retardation (74). Bacterial 
resistance to tetracyclines are largely due to acquired resistance; resistant strains emerge from 
previously sensitive bacterial populations by acquisition of resistance genes (usually residing 
in plasmids and/or transposons) (55). Resistance to tetracyclines may be mediated by one of 
the following mechanisms; (a) an energy-dependent efflux of tetracycline carried out by 
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transmembrane proteins, which results in the reduction of the concentration of tetracycline in 
the cytosol; (b) ribosomal protection, whereby the tetracyclines no longer bind productively 
to the bacterial ribosome; or (c) chemical modifications requiring oxygen and NADPH as 
well as catalysis by enzymes (55). 
Erythromycin 
    In 1952, while examining soil samples from the Philippine archipelago, J.M. McGuire and 
his colleagues at Eli Lilly discovered erythromycin, the prototype and first antibiotic in the 
class of macrolides (76). The name “macrolide” is derived from “macro” (large) and “olide” 
(lactone) (12, 74). The natural macrolide antibiotics (such as erythromycin) are isolated 
primarily from the genus Streptomyces (55). Most macrolides are weak bases and are 
unstable in acids (83). The action of macrolides can be bactericidal or bacteriostatic, the 
effect depending on the concentration and the type of microorganism targeted by the drug 
(76). Macrolides bind to the 50S subunit of the bacterial ribosome and inhibit the 
transpeptidation and translocation process, causing premature detachment of incomplete 
polypeptide chains (55). The antimicrobial spectrum of erythromycin is very similar to 
penicillin; it has proved to be a safe and effective alternative for penicillin-sensitive patients 
(76). Macrolides are effective against Gram-positive bacteria and spirochetes but not against 
most Gram-negative organisms, the exceptions being Neisseria gonorrhoeae and 
Haemophilus influenzae (76).  Mycoplasma pneumoniae, Legionella species and some 
chlamydial organisms are also susceptible (76). The macrolides are administered orally and 
intravenously. They diffuse readily into most tissues, but do not cross the blood-brain barrier; 
additionally there is poor penetration into synovial fluid (76).The majority of side effects 
associated with macrolides are mild and transient. As a class they are generally well-tolerated 
(74). The most common complaints involve the gastrointestinal tract and include diarrhea, 
nausea, vomiting and abdominal pain (74). Patients may complain of an abnormal or metallic 
aftertaste (74). Hepatotoxicity is a very rare but serious side effect associated with the 
estolate salt of erythromycin (74). Three different mechanisms account for bacterial 
resistance to the action of macrolide antibiotics; (a) target site modification (b) active efflux 
and (c) enzymatic inactivation (55). Some bacterial species are able to synthesize enzymes, 
encoded by a series of structurally related erythromycin-related methylase (erm) genes which 
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methylates rRNA (55). Methylation of the 23S rRNA of the 50S subunit leads to a 
conformational change of the ribosome that yields broad-resistance to macrolides (55). The 
marcolide-specific efflux from resistant cells is driven by a membrane protein encoded by the 
macrolide efflux (mef) gene (55). The genes of the efflux pumps can be either acquired (such 
as mef), or carried intrinsically, such as acriflavine resistance AB (acrAB)  (33) The clinical 
significance of enzymatic degradation is still being characterized (33).  Members of the 
family Enterobacteriaceae are highly resistant to erythromycin due to erythromycin esterases 
encoded by the erythromycin resistant esterases, ereA and ereB (33).  
Nalidixic acid 
    The quinolones, also referred to as fluoroquinolones are synthetic in origin (33). Nalidixic 
acid is considered a first-generation quinolone; technically nalidixic acid is not a 
fluoroquinolone because it is not fluorinated like other quinolones (76). Most fluroquinolones  
exhibit large chemical stability (83). They are insensitive to hydrolysis and increased 
temperatures but are degraded by ultraviolet light (83). Nalidixic acid was introduced into 
clinical practice in 1963 and initially restricted to the treatment of urinary tract infections in 
humans (12). It has a narrow Gram-negative treatment range and limited tissue distribution 
when taken orally (74).  Intravenous administration is ill-advised because of issues such as 
poor tolerance (12). Even though nalidixic acid has a limited place in therapy, it served as the 
prototype for new classes of fluoroquinolones (12). In the 1980s, it was discovered that the 
basic structure of nalidixic acid could be manipulated. This resulted in agents with a broader 
spectrum of antibiotic activity, better tissue distribution, and improved pharmacokinetics (the 
fate of pharmaceutical substances administered to a living organism) (12). These “second 
generation” fluoroquinolones include ciprofloxacin, ofloxacin, and enoxacin (12). Third and 
fourth generation fluroquinolones were later developed (examples are gatifloxacin and 
gemifloxacin, respectively) (74). These antibiotics were found to expand Gram-negative and 
atypical pathogen coverage (74). Fourth generation fluoroquinolones further improved Gram 
positive and Gram-negative coverage in addition to being more effective with anaerobic 
pathogens than previous generations of fluoroquinolones (74). However, there were instances 
in which some third and fourth generation fluroquinolones had to be withdrawn from use 
because of  side effects such as cardiac arrest and serious liver injury (74). 
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    Fluroquinolones can be administered orally, intravenously or by intramuscular injection 
(12). The drugs are well-absorbed, particularly in the kidneys, prostrate and lung (76). The 
mechanism of action of fluoroquinolones has not been clearly defined, but they inhibit 
bacterial DNA synthesis by inhibiting the enzymes DNA gyrase and topoisomerase IV (33, 
74). DNA gyrase is an essential enzyme in bacterial replication and is responsible for 
producing a negative supercoil in DNA-permitting transcription or replication (76). 
Topoisomerase IV separates interlocking daughter DNA strands that form during replication. 
This facilitates the segregation of daughter DNA molecules into daughter cells (33). The 
fluoroquinolones are generally well-tolerated, although the frequency of ill effects may 
increase with higher dosage (74). The most common side effects are gastrointestinal 
(primarily nausea, diarrhea, vomiting and anorexia) (74). Adverse reactions involving the 
central nervous system can also take place-occurring in 1-3% of patients taking 
fluoroquinolones (74). Symptoms including headaches, anxiety, and tremors (74). There have 
been reports of cartilage damage in young animals, therefore fluoroquinolones are not 
recommended for use in children, pregnant women, or nursing mothers (74). 
Fluoroquinolones can be used for the treatment of nosocomially-acquired pneumonia, 
bronchitis, sinusitis and exacerbations of cystic fibrosis (74). However, broad use of 
fluoroquinolones have been followed by emergence of resistance, which is due mainly to 
chromosomal mutations in genes encoding subunits of the drugs’ target enzymes (DNA 
gyrase and topoisomerase IV), in genes that affect the expression of diffusion channels in the 
outer membrane, and in multidrug-resistance efflux (MDR) systems (12, 33). 
Fluoroquinolone resistance resulting from multidrug efflux pumps have been found in a 
number of Gram-negative organisms including Campylobacter jejuni, Escherichia coli and 
Salmonella typhimurium (55). 
Penicillin 
    The discovery of penicillin represented an extraordinary event in the study of infectious 
disease because it enabled a number of infections to be treated that previously caused chronic 
illness or death (12). It transformed not only medicine but also the socioeconomic events of 
the second half of the 20th century (12). Penicillin was derived from the fungus Penicillium 
notatum and discovered in 1928 by the Scottish microbiologist Alexander Flemming at St. 
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Mary’s Hospital in London, England (76). Flemming had inoculated nutrient agar with 
staphylococci and left for a vacation. On his return, he noted that one plate was contaminated 
with green fungus. Flemming became interested in the antibacterial properties of the fungus 
when he noticed the failure of staphylococci to grow near the mold (73). Despite Flemming’s 
efforts, he was not able to purify what is now known as penicillin (73). Twelve years later 
Howard Florey and Ernst Chain of Oxford University completed studies on the fungal 
metabolites of P. notatum and was able to purify the substance (12). Florey and Chain began 
to study penicillin and its clinical usefulness in treating infections. Initially, they completed 
tests in tissue cultures and animals (74). In February 1941, a 43-year-old Oxford policeman 
was the first to receive penicillin. He was diagnosed with an overwhelming staphylococcal 
septicemia with numerous accesses in the lungs, bone and face. Multiple doses of penicillin 
were given intravenously and after 5 days, the patient showed significant improvement. 
Unfortunately, the supply of penicillin ran out. Despite attempts at recovering penicillin from 
the patient’s urine and purifying it for reuse, the patient died a month later (74). Because of 
England’s involvement World War II, their scientists were not able to mass produce 
penicillin. A group of American companies developed the techniques for large scale 
production and later made the drug available for commercial use (73). In 1945, Flemming, 
Florey and Chain shared the Nobel Prize in Physiology or Medicine for the discovery and 
development of penicillin (73). Since the 1940s, penicillin has remained the most widely 
used antibiotic because of its low costs and thousands of derivatives (73). 
    Penicillins are characterized by a four-membered ß-lactam ring fused to a five-membered 
thiazolidine ring containing a side chain (53). Manipulation of this side chain is important in 
the pharmacodynamics of penicillin (53). Penicillins are classified on the basis of 
antibacterial activity into subclasses including natural penicillins, penicillinase-resistant 
penicillins, aminopenicillins (which includes ampicillin), carboxypenicillins and 
ureidopenicillins/piperazine (74). The activity of penicillin is directly dependent on the ß-
lactam ring (83).The ring is easily cleaved in acidic and basic media (83). Aminopenicillins 
were the first group of penicillin antibiotics to have activity against both Gram-positive and 
Gram-negative bacteria (broad-spectrum activity) (74). Most penicillins can be given orally, 
intramuscularly, and intravenously (74). A few (such as most carboxypenicillins and 
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ureidopenicillins/piperazines) are given intramuscularly or intravenously (74). Penicillins are 
often combined with other antibiotics to enhance antibacterial chemotherapy (74). All ß-
lactam antibiotics interfere with the synthesis of the bacterial cell wall peptidoglycan. After 
attachment to binding sites on bacteria (termed penicillin binding proteins), they inhibit the 
transpeptidation enzyme that cross-links the peptide chains attached to the backbone of the 
peptidoglycan (74). Bacteria can become resistant to penicillin by the production of ß 
lactamases, enzymes that can be released in the external medium (in the case of Gram-
positive bacteria) or in the periplasmic space (in the case of Gram-negative bacteria) (12). 
Reduction in permeability and a modification in target penicillin binding proteins have been 
described for some bacterial species such as Staphylococcus aureus and Streptococcus 
pneumoniae (12). A major disadvantage of penicillin use is anaphylactic reactions that 
appear in some patients (73). Allergic reactions such as swelling around the eyes and wrists, 
flushed or itchy skin, shortness of breath, and hives are signals that sensitivity exists and 
penicillin therapy should cease (73). 
Antibiotic Resistance 
    Resistance is defined as the relative insusceptibility of a microorganism to a particular 
treatment under a particular set of circumstances (48). Some researchers believe that 
resistance is an ecological phenomenon stemming from the response of bacteria to the 
widespread use of antibiotics and their presence in the environment (24, 51). They believe 
that the rise in the frequency of antibiotic resistance among pathogens should be a “cause of 
great concern” and suggest “a commitment to act responsibly” (89). For example, before 
human patients were first treated with antibiotics (65 years ago), bacteria isolated from 
patients had almost no resistance genes (69).  However, after each new agent became widely 
used, a gene expressing resistance to it ultimately emerged (69).They believe that human and 
veterinary medical staff, public health officials, the pharmaceutical industry and those 
involved in agriculture must work together to “curb the inappropriate use of antibiotics” and 
promote responsible prescribing (89). Others believe that there is a “concerted attack” on the 
use of antibiotics, and that antibiotic resistance is as ancient as bacterial organisms since 
bacteria are able secrete products (antimicrobials) to prevent attack from other competitive 
organisms (72). They believe that the actual risk of antibiotic resistance is quite small and 
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independent investigations “free of commercial and political influence” are necessary to 
study the issue (72). Additionally, mathematical models have been developed in which the 
effects of antibiotic resistance on human health, hospitalizations and mortality were studied 
(21). These models determined the use of antibiotics in food animals creates (at most) minor 
risks to human health (21). Despite of the ongoing debate, a majority of researchers believe 
that the spread of antibiotic-resistant pathogens is a problem in the US and around the world-
despite the few studies that state differently (17, 19, 37, 42). A report by the World Health 
Organization (WHO) cited antibiotic resistance as one of the most critical human health 
challenges of the next century and heralded the need for a “global strategy” to contain 
resistance (24). For example, antibiotic resistance in Campylobacter jejuni is characterized as 
a global problem (32). In countries with lax restrictions on human and animal treatment, very 
high levels of antibiotic resistant Campylobacter were observed (32). There continues to be 
much debate regarding the role of antibiotics in animal husbandry and veterinary 
therapeutics-and the relationship of dissemination of bacterial resistance mechanisms (32). 
The Family Enterobacteriaceae 
   Members of the family Enterobacteriaceae have earned a reputation placing them among 
the most pathogenic and frequently encountered organisms in microbiology (20). The name 
Enterobacteriaceae is misleading because it obscures its members’ wide variety of habitats 
including water, soil, food plants, trees and animals (from humans to insects) (52). 
Researchers have divided the family-based on their associations; (a) insect 
pathogens/symbionts (e.g. Buchnera and Xenorhabdus); (b) animal pathogens (e.g. 
Salmonella and Escherichia); (c) plant pathogens (e.g. Erwinia and Samsonia) and (d) those 
genera used for industrial purposes (e.g. Alterococcus and Pragia) (35). Substantial growth 
has occurred within the family Enterobacteriaceae; from 11 genera and 26 species in 1972 to 
22 genera and 69 species as of 2006 (35). Enterobacteriaceae are Gram-negative rods, have 
an aerobic or facultative anaerobic metabolism, are oxidase negative, catalase positive and 
ferments D-glucose (35). In addition, they reduce nitrates to nitrites, do not require sodium 
for growth, and has a G+C content from 38-60 % (35). There are minor exceptions within 
species or groups, however most Enterobacteriaceae possess the characteristics previously 
listed (27). Many species are of considerable economic importance. For example, Erwiniae 
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causes blight, wilt, and soft-rot disease in crops such as corn, potatoes, pineapple and sugar 
cane while Klebsiella can cause disease in cattle, turtles, humans and lizards (27).  
Salmonella 
   Salmonellae are facultative, gram-negative, motile rods (0.7-1.5 X 2.0-5.0 um) and are 
members of the family Enterobacteriaceae (10, 59).  Non-typhoidal salmonellae, which 
includes > 2500 serotypes (or serovars) are widely distributed in nature, including the 
gastrointestinal tract of mammals, reptiles, birds, and insects (79). For the purpose of this 
work, serotypes of Salmonella enterica, subspecies enterica will be referred to as Salmonella 
accompanied by the serotype name (80); for example S. enterica subspecies enterica 
serotype London will be referred to as Salmonella london. Most salmonellae are motile, 
however, the serotypes gallinarum and pullorum are non-motile (10). Serotyping is based on 
the somatic (O) lipopolysaccharide on the external surface of the bacterial outer membrane, 
flagellar (H) antigen associated with the peritrichous flagella, and capsular Vi (or virulence) 
antigens (61). Salmonella serotypes may be strictly adapted to one host, ubiquitous (found in 
a large number of animal species) or may be of still-unknown pathogenecity (10). Serotypes 
adapted to humans (such as S. typhi) usually cause severe disease with a septicemia-typhoidic 
syndrome, while ubiquitous serovars are mainly responsible for food-borne infections (10).  
   Infection by Salmonella enterica is a significant health concern world-wide (26). Human 
salmonellosis occurs in about 1.3 million people, causes > 500 deaths and is estimated to cost 
the US economy a 2.3 billion to 3.6 billion each year (14, 26). Many human illnesses can be 
linked to the consumption of bacterially contaminated ground beef, milk, or other dairy 
products (14). Direct contact with infected animals can also serve as a source for Salmonella 
infection (26). Most infections on cattle farms are introduced by the purchase of infected 
cattle (79, 84). One study demonstrated that the introduction of newly purchased cattle to a 
farm increased the risk of salmonellosis, and that the period of highest risk was within one 
month of arrival (84). The most recent reported national dairy survey (USDA’s NARMS) 
indicated that 27 to 31 % of US dairy herds contained cows that shed Salmonella (14). 
Salmonella have been isolated from the feces of healthy cattle (where it may exist as a 
normal member of the gastrointestinal flora), or as a transient member of the gastrointestinal 
microbial population (14). Illness from salmonellosis in the bovine is seen predominantly in 
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young calves although it is sometimes seen in adult cattle (14). Host-specific serotypes of 
Salmonella (such as S. dublin) can cause diseases such as abortion or severe gastroenteritis 
(26). However, ubiquitous serotypes can cause sub-acute septicemia and acute enteritis. In 
the subclinical form of the disease, animals may either have a latent infection or become a 
temporary or persistent carrier (26). 
     In the US, infections with multi-drug resistant S. newport have emerged in recent years; 
the primary reservoir is thought to be bovine (79). Additionally, multi-drug resistant 
serotypes of Salmonella are associated with increased hospitalization and increased mortality 
and morbidity in many region of the world, including the United States (30). Pasteurization 
of milk effectively kills Salmonella, but consumption of unpasteurized milk and milk 
products is a well-documented risk factor for human salmonellosis (79). Furthermore, 
unpasteurized milk and milk products contaminated after pasteurization are recognized 
sources of human disease (79).    
Campylobacter 
    Campylobacter is a member of the family Campylobacteraceae (81). The organism can 
establish long-term associations with their hosts, sometimes with pathogenic consequences 
(81, 90). Campylobacter cells are Gram-negative, slender and spirally curved rods (from 0.2-
0.8  X 0.5-5 um)  (65). Cells in old cultures may form coccoid bodies (65). Most species of 
Campylobacter are motile with a characteristic corkscrew-like motion by means of a single 
polar unsheathed flagellum at one or both ends (65). Most species are microaerophilic 
requiring 3-15% oxygen and 3-5% carbon dioxide for growth (59, 61). In a laboratory 
setting, campylobacters require selective media (32). All Campylobacter grow best at 37°C, 
but some Campylobacter species (C. jejuni, C. coli and C. lari) grow best at 42°C (43, 59). 
The organisms are more sensitive to adverse conditions (e.g. drying, heat, disinfectants, 
acidity) than most other enteric pathogens (59).  This suggests that they are best adapted for 
existence in vivo.  
    The genus Campylobacter is capable of surviving in a wide range of environments. It has 
been isolated from rivers, estuarine and costal waters (43) as well as in sand, soil, and sewage 
(9). C. jejuni can remain dormant in water (in a viable but nonculturable or VBNC state) 
(61). Campylobacter is a commensal organism routinely found in cattle, sheep, swine and 
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avian species (61). For this reason campylobacteriosis is considered a zoonotic disease (2). In 
the United States, an estimated 2.4 million cases of human campylobacteriosis occur each 
year (6). Campylobacter species are one of the most common causes of bacterial diarrhea in 
humans worldwide (2).  Two species are usually associated with most human infections, C. 
jejuni and C. coli (2).  C. jejuni are estimated to cause 90% of human infections (36). The 
estimated rate of campylobacteriosis (number of cases/100,000 individuals) differ strongly 
around the world, with New Zealand as the country with the highest rate (396/100,000 
persons), compared to the United States (reported as being 12.7/100,000 persons by FoodNet 
in 2005) (36). Doses as low as 500 organisms have been reported to cause illness (36). The 
most common clinical symptoms of human campylobacteriosis are fever, abdominal pain, 
vomiting, bloody stools and diarrhea that occur within 2-5 days of ingestion of food or water 
contaminated with Campylobacter (9, 36). The illness is usually self-limiting and is resolved 
within a period of 3 to 10 days; most cases do not require the use of antibiotics. When 
antibiotics are necessary, erythromycin (a macrolide) and fluroquinolones are usually 
prescribed; complications are rare (9, 36). In a small sub-group of patients, the acute phase is 
followed by serious sequelae: Guillain-Barre syndrome (GBS) and Miller-Fisher Syndrome 
(36). GBS is a serious autoimmune-mediated neurological disorder that can cause symptoms 
ranging from weakness of extremities to complete paralysis and respiratory distress (36). 
Miller-Fisher Syndrome is characterized by lack of general muscle coordination and 
coordinated eye movements. (11, 62, 65)  
   Cattle are common carriers of Campylobacter and the importance of raw milk as a risk 
factor for human campylobacteriosis has been recognized in epidemiologic studies. 
Consumption of unpasteurized milk has been associated with outbreaks (31). 
Additionally, the environmental load of Campylobacter in cattle manure may be a more 
significant factor in the transmission of infections than contaminated milk or beef (6, 31). 
Campylobacter has long been recognized as a cause of diarrhea in cattle and of septic 
abortion in both cattle and sheep (43, 65).  
Enterococcus 
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     The enterococci (family Enterococcaceae) belong to the clostridial subdivision of the 
Gram-positive bacteria and consists of 27 species (49) that are divided into four groups, 
based on tests such as 16S rRNA gene sequencing and phenotypic analyses (28). The 
name “entérocouque” was first used by Thiercelin in a paper published in 1899 and was 
proposed to emphasize the intestinal origin of this newly discovered organism (63). In 
1903, Thiercelin and Jouhaud proposed the generic name “Enterococcus” with type 
species Enterococcus proteiformis (41). However, in 1906, Andrewes and Holder 
renamed the genus and species “Streptococcus faecalis”, based on its ability to form short 
or long chains, and the ability to form hemolytic, greening colonies on media (41). With 
the establishment of the Lancefield serological typing system in the 1930s, enterococci 
were reclassified as group D streptococci and differentiated from the non-entercoccoal 
streptococci by distinctive biochemical characteristics (16). In 1984, Enterococcus 
became recognized as a separate genus from Streptococcus (1). Schleifer and Kilpper-
Bälz revived the name Enterococcus when Streptococcus faecalis and S. faecium were 
transferred to the genus Enterococcus (46). Enterococcus are ubiquitous microorganisms, 
but have a predominant habitat in the gastrointestinal tract of humans and farm animals 
(29). Enterococcus, as members of commensal flora, are present in the human colon in 
numbers as high as 108 colony forming units (CFUs) per gram of feces (82). Enterococci 
can also be found in different types of food and feed (29, 46). Some enterococcoal strains 
are used as starter or protection cultures, feed supplements, and probiotics (46). 
Traditionally enterococci are considered part of the lactic acid bacteria (LAB) group (46). 
LAB are Gram-positive, non-sporeforming, microaerophilic/anaerobic, and catalase 
negative (46). They also form lactic acid and other products (ethanol and acetic acid) 
after fermentation of carbohydrates (46). 
    Enterococci are important opportunistic pathogens and now rank among the most 
common nosocomial agents infecting the bloodstream, surgical sites, and urinary tract 
(82). The role of enterococci in infective endocarditis and urinary tract infections (UTIs) 
are well-established (63).  Enterococcus-related endocarditis accounts for 5-10% of the 
total bacteria endocarditis cases reported each year (82). UTIs are the most common 
nosocomial infections caused by enterococci; they account for about 34–46% of all 
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infections in hospitals and occur at a rate of 13 cases per 1000 discharges (91). Many 
enterococcus-related illnesses are becoming more difficult to treat because of growing 
resistance to antibiotics (82). Since its discovery as a human pathogen, members of the 
genus Enterococcus have distinguished themselves from other Gram-positive cocci by 
multiple antibiotic resistance (60). Vancomycin-Resistant Enterococcus (VRE) were first 
identified in the mid 1980s (16). VRE has become a major problem in institutions in 
Europe and the United States (16). Since VRE have intrinsic resistance to most of the 
commonly used antibiotics and the ability to acquire resistance (either by mutation or 
receipt of foreign genetic material), they have a selective advantage over other 
microorganisms in the intestinal flora and pose a major therapeutic challenge (16). 
Antibiotic Susceptibility Testing  
    Antimicrobial susceptibility testing methods have been in use since 1929 to estimate 
the effects of antibiotic agents on microorganisms (74). Routine results are obtained by 
placing antibiotics and organisms together in a medium which will support growth. 
Methods such as agar diffusion, broth dilution, or agar dilution are frequently used in 
microbiology (74). Diffusion and dilution methods are used to determine the minimum 
inhibitory concentrations (MICs) of antimicrobial agents (40). The agar diffusion test is 
also referred to as the Kirby-Bauer Disc Method. Dried filter paper impregnated with a 
defined concentration of antibiotic is placed on the surface of an agar plate that has been 
uniformly inoculated with the bacterial organism in question (53). After incubation, the 
plate is reviewed for zones of inhibition. The zone diameters for individual antibiotics are 
translated in terms of being “susceptible”, “intermediate” or “resistant” (53).  The terms 
“resistant” and “susceptible” are often used to express the ability (or lack of ability) of a 
microorganism to multiply in the presence of a given concentration of antibiotic under 
defined conditions (8). The “intermediate” category refers to organisms not clearly 
resistant or fully susceptible; this designation is considered a “buffer zone” in terms of 
interpretation: for example, during clinical diagnosis, a patient with an “intermediate” 
result may be given a higher dosage of antibiotic (53). Disc diffusion testing has the 
advantages of simplicity and low cost, however there can be difficulty in the 
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interpretation of zone diameters-especially with slow-growing bacteria (22, 53). Another 
version of the agar diffusion test is referred to as the E-Test (54). The E-Test is an MIC 
test which a uses a thin plastic strip coated with a continuous antimicrobial agent on one 
side and a quantitative interpretative scale on the other side (54). MICs are determined by 
reading the antimicrobial concentration printed on the test strip at its intersection with the 
growth inhibitory zone (54). Because the E-Test comprises a continuous gradient, MIC 
values between two-fold dilutions can be obtained (84). E-Tests results are as accurate as 
agar dilution tests (incorporation of an antibiotic in an agar medium) (54), however 
unusual zone patterns can lead to MIC discrepancies for some organisms (84).  
Additionally, the high cost of the E-Test makes it more useful for a limited number of 
drugs under special circumstances (such as when quantitative susceptible data is 
necessary for treatment of persistent infections) (84).  
     The principle of broth dilution is the exposure of a given inoculum of bacteria to 
varying concentrations of antibiotic, each placed in an individual tube containing nutrient 
broth (53). After appropriate incubation, the minimal lethal concentration (MLC) is 
determined by identifying the tube containing the lowest concentration of antibiotic that 
inhibits growth (53). Standard broth dilutions are more convenient when only a few 
strains need to be tested against one or two drugs (74). With mechanization of the 
procedure, one isolate can be tested against a large number of drugs with reasonable 
efficiency (74). Another advantage of the broth dilution method is that minimum 
bactericidal concentration (MBCs) may be determined by subculturing each tube showing 
no visible growth to a portion of a non-antibiotic containing blood agar plate (53). Plates 
are then incubated and the MBC is read as the lowest concentration of drugs which show 
no growth on the agar plate surface (53). A major disadvantage of broth dilution is that 
when fastidious organisms are tested, supplements often have to be added to the broth. 
However, supplements can produce a cloudy medium in which microbial growth is 
difficult or impossible to detect (74). When a large number of isolates require testing, 
broth dilution can be adapted to what is called broth microdilution testing (53). Broth 
microdilution testing is more economical and efficient than broth dilution. For each 
organism being tested, as many of 12 different concentrations of 8 antimicrobials can be 
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tested on a specially prepared 96-well microtiter plate (53). Still, it can be difficult to find 
standard test panels since manufacturers may use different antibiotic formulas (39).  
    Agar dilution involves the incorporation of an antibiotic agent into an agar medium 
followed by the application of a bacterial inoculum to the agar surface of the plate (87). 
Stock solutions of antibiotics are prepared by weighing laboratory standard powders and 
dissolving them in distilled water or some other suitable diluent (7, 53). Antibiotics are 
aseptically added once the agar has been autoclaved and is cooling (53). The antibiotic is 
mixed into the molten agar and poured immediately (53). As with broth dilution, the agar 
dilution method provides a quantitative result in the form of an MIC, in contrast to disk 
diffusion that result in an indirect measure of susceptibility and provides a qualitative 
interpretative result (74). Some advantages offered by agar dilution include accurate 
determination of MICs, the ability to test many organisms against a series of a single 
antibiotic at the same time, the potential to extend the antibiotic concentration as far as 
required and adaptation to semi-automation (i.e. using automated technology such as a 
plate pourer to make large amounts of plates) (87). The agar dilution method is known as 
the “gold standard” of antibiotic susceptibility testing, however it is rarely preformed due 
to the large amount of manual handling that is needed (87). Agar dilution requires 
extensive training, is expensive and labor-intensive (especially when testing many 
organisms against many antibiotics) (32, 87). An agar dilution method has been 
standardized by the Clinical and Laboratory Standards Institute (CLSI)b, formerly the 
National Committee for Clinical Laboratory Standards (NCCLS) (47, 87).  
The consequences of antibiotic resistance in humans and animals and the “prudent” 
use of antibiotics 
    Two human health consequences of increasing antibiotic resistance are an increase in 
food-borne illnesses and an increase in the number of treatment failure (4). Antibiotic 
resistance is believed to be associated with greater mortality, morbidity, and costs than  
bThe CLSI is a large, independent group of individuals representing professional societies, industries, and 
governmental agencies, all which have a common interest in the operation of clinical laboratories (7). CLSI 
is organized for the promotion and development of national and international standards that are needed for 
proper activity and operation of clinical laboratories (7). 
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infections due to susceptible organisms (15). The national costs of antimicrobial resistance 
for the United States have been estimated between $100 million and $30 billion dollars 
annually (15). The Office of Technology Assessment of Congress have estimated the minimal 
hospital cost associated with human nosocomial infections caused by antibiotic-resistant 
bacteria to be $1.3 billion per year (15).  
    There are significant concerns regarding MDR and the safety of the food supply-
particularly with enteric bacteria such as Salmonella and Campylobacter (3, 15). Limited 
studies exist regarding the prevalence of antibiotic resistance among dairy herds (77). The 
exact reason for the emergence of drug-resistant stains of bacteria remains unknown, but 
selective pressure is partially to blame (25). It has been suggested that using subtherapeutic 
doses of antimicrobials in animal feedstuffs has led to an increase in the number of resistant 
strains of common and pathogenic bacteria (25). In addition, dairy and beef products have 
been implicated as a source of Salmonella responsible for human outbreaks. Beef and dairy 
herds may also represent a reservoir for transmission of antibiotic-resistant Salmonella to 
humans (25, 26).  Milk, poultry, pork and untreated water have been linked as possible 
vehicles of transmission of Campylobacter (88). However most studies of Campylobacter 
resistance are primarily based on poultry products, especially broiler meat (23). Animals such 
as raccoons, rodents and birds have been implicated in transferring disease in dairy farm 
environments (75). Feedstuffs and factors such as animal management practices and waste 
management/effluent control have also been implicated (75). Denmark and Sweden decided 
to curb their use of antibiotics as growth promoters; this has been associated with reduced 
antimicrobial resistance and decreased public health risks (17). In addition, members of the 
United States Congress have introduced legislation to enact similar bans. (78) Conversely, 
there are studies in which the resistance level remained constant or even increased 
independent to decreasing the use antimicrobial drugs (45). Although it is not completely 
understood how widespread the frequency of antibiotic resistant bacteria is in the non-
nosocomial community, the lack of surveillance data are especially evident in important 
agricultural environments, such as dairy farms (13).  
    The “prudent” (appropriate) use of antibiotics is an important step in decreasing antibiotic 
resistance. For example, extensive antibiotic resistance programs have been set up in several 
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European countries (Denmark, Sweden, Germany and the United Kingdom)  (44, 86). The 
movement to restrict the use of antibiotics in livestock production is also growing in North 
America (57). Organizations such as the Union of Concerned Scientists (UCS) have charged 
that antibiotic production in the US is greatly underestimated and the Center for Science in 
the Public Interest (CSPI) is lobbying the Food and Drug Administration to have seven 
antibiotics banned from agricultural use (57). They include penicillin, tetracycline, 
erythromycin, tylosin, lincomycin, virginiamycin and bacitracin (34, 57). Other organizations 
are urging a more measured approach, including modifying prudent use guidelines as new 
scientific evidence on antibiotic resistance becomes available, encouraging responsible use of 
antibiotics and using risk assessment to determine the public health impact of antibiotic 
resistance (34, 71). The World Health Organization (WHO) has repeatedly concluded that 
data on the usage of antimicrobial agents are essential for focusing on efforts to reduce use 
and misuse of antimicrobial agents (67). McAllister et al. (2001) have listed important 
criterion to consider in order to minimize the use and misuse of antibiotics in livestock 
production; (a) do not use antibiotics to compensate for poor nutrition, poor hygiene, or the 
lack of immunization or implementation of a herd health program;  (b) consider other 
methods of intervention (e.g. proper nutrition, stress management) prior to antibiotic therapy; 
(c) use antibiotics in consultation with a veterinarian; (d) select dosing rates and treatment 
periods in accordance with manufacturer’s recommendations; (e) maintain accurate treatment 
records; and (f) whenever possible, culture suspected pathogens for identification, to ensure 
that the selected antibiotic is targeting the causative organism (57). Such actions will require 
collaborative efforts by several partners, including the farming, veterinary, medical and 
public health communities (4). Enhanced surveillance is important; there is a particular need 
to establish surveillance of antibiotic usage in animals (4). 
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The establishment and proliferation of antibiotic-resistant Campylobacter on a new 
dairy farm prior to and after the placement of dairy cattle 
 
Ginger M. Shipp and James S. Dickson 
 
Abstract 
 
Campylobacter has been recognized as the most common cause of gastroenteritis in the 
United States. Most cases of campylobacteriosis are self-limiting, but can be fatal in infants, 
young adults and the immunocompromised. Cattle contribute to human cases and outbreaks 
through several transmission routes, such as direct contact, environmental contamination, and 
milk. A longitudinal study on the antibiotic resistance of Campylobacter was conducted on a 
teaching farm (dairy) before and after the introduction of cattle. Resistance to tetracycline, 
erythromycin, and nalidixic acid were examined. These antibiotics are the treatment of 
choice for human patients and there is concern about emerging resistance. Environmental 
drag swab samples were taken from select farm locations over a 9-month period, plated on 
selective media (Preston agar) and replica plated on tryptic soy agar (TSA) containing a 
predetermined amount of antibiotic. Antibiotic-containing TSA plates were made following 
guidelines of the Clinical and Laboratory Standards Institute (CLSI) and the National 
Antimicrobial Research Monitoring System (NARMS). Generally, the numbers of 
Campylobacter colonies increased after placement of dairy cattle. Additionally, antibiotic-
resistance profile evolved from resistance to one antibiotic (beginning in F samples) to 
multidrug resistance (also from F samples to the conclusion of the study). Time was more a 
factor in the increase in multidrug resistance-more so than factors such as temperature and 
humidity (however, this study was conducted over a 9-month period). Longitudinal studies 
are important in providing insight into the dynamics of endemic diseases of dairy herds and 
because of variations found in this (and other) work, it is important to continue monitoring of 
pathogens in the farm environment.  
   
Key words: longitudinal study, dairy farm, erythromycin, tetracycline, nalidixic acid, drag 
swabs, replica plating, NARMS, CLSI. 
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  Since the 1970s Campylobacter has been recognized as the most common cause of 
gastroenteritis in the United States (17). Illness caused by Campylobacter range in severity 
from slightly loose stools to watery diarrhea (often with blood), lasting 3-5 days (27). Most 
infections are self-limiting, but occasionally are fatal in infants and young adults (4, 27). 
Immunocompromised patients (such as those with the Human Immunodeficiency Virus or 
those undergoing chemotherapy) are at a higher risk of severe illness and hospitalization 
(27). A small number of patients develop debilitating sequelae such as Guillain-Barré 
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syndrome (acute flaccid paralysis) and Miller Fisher syndrome (a variant of Guillain-Barré 
syndrome characterized by lack of muscle coordination, absence of neurological reflexes and 
lack of coordinated eye movements) (4, 36, 37). A majority of Campylobacter infections (≈ 
90%) are attributed to C. jejuni although C. coli is increasingly being recognized as an 
important pathogen (4, 46). C. jejuni is generally regarded as microaerophilic (growing in 
environments containing 3-5% CO2 and 3-15% O2), and thermophilic (or theromtolerant), 
growing in a small temperature range from 30º C to 45º C (52). Major environmental 
reservoirs of Campylobacter reside in the intestines of birds and warm-blooded mammals, 
where it is thought to be commensal with the gut flora, rather then pathogenic, at least in 
older animals (50).  
   Most Campylobacter infections are believed to result from the ingestion of contaminated 
food, although the role of non-food exposure in the epidemiology of sporadic 
campylobacteriosis is still unknown (4). The primary source of contamination is believed to 
be animal feces (4). Contamination of the environment by domestic and wild animal feces 
(and that of humans) presents an alternative exposure pathway for human infection via 
drinking and recreational water use (4). Humans may also be exposed to voided animal feces 
in the environment through outdoor activities such as camping, hiking and picnicking (4). 
Cattle contribute to human cases and outbreaks through several transmission routes such as 
direct contact, environmental contamination (via feces) and milk (4, 11). C. jejuni and C. coli 
commonly colonize cattle without causing symptoms and studies have reported that 40-60% 
of individual animals and 80% of herds shed Campylobacter (11). Consumption of 
unpasteurized or inadequately pasteurized milk have been identified as a source of 
campylobacteriosis and is believed to be associated with both outbreaks and sporadic cases 
(11). Campylobacter spp. are recognized as a cause of septic abortion, infectious infertility 
and diarrhea in cattle (48). 
    The emergence of strains of Campylobacter (and other bacterial pathogens) resistant to 
antibiotics used to treat disease has provoked controversy over the use of antibiotics in food 
production (13). Many researchers believe that antibiotic resistance is a growing concern for 
public and animal health (18, 30) and feel much of the antibiotic use in human and veterinary 
medicine is unwarranted (26, 39). Solutions range from the elimination and/or responsible 
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use of antibiotics (28, 35, 38) to the investigation and use of alternatives such as antibiotic 
efflux pump inhibitors (31), probiotics (bacterial organisms that may be antagonistic to 
microbial pathogens) (49), and proper animal management (age-separation, vaccination and 
sanitation) (35). Conversely, others believe that antibiotics produce demonstrated benefits 
including improved animal health, higher production and reduction in foodborne pathogens 
(7, 34). Mathematical models have been developed to study foodborne disease, human 
hospitalizations, and mortality (9). The models determined that the use of antibiotics in food 
animals creates (at most) minor risks to human health.  Many believe that additional research 
is necessary before antimicrobial use is further limited or banned (43). 
   Antibiotic resistance in Campylobacter isolated from poultry production has been well-
documented in studies (12, 21, 29). Additionally, there are many reports on foodborne 
outbreaks of Campylobacter (1, 24, 45). In contrast, there are few studies on antibiotic 
resistance in Campylobacter isolated from cattle farms (13). Of these studies, some involve 
antibiotic resistance in udder pathogens (3, 47), in lactating cattle (23), and the prevalence of 
Campylobacter in regions including northern Thailand (41), and the Midwestern and 
northeastern United States (20, 48). In a study of antimicrobial resistance of Campylobacter 
in the feces of US dairy cows, 47 % of the isolates of C. jejuni were resistant to tetracycline, 
4 % to nalidixic acid, and 2% were resistant to erythromycin (15). Other studies demonstrate 
an increase in multidrug resistance in both C. jejuni and C. coli (2, 5). Mastitis is the most 
common condition that justifies the use of antimicrobials on dairy operations (8) and is 
caused by a variety of Gram positive and Gram negative organisms including Staphylococcus 
aureus, Escherichia coli and Klebsiella spp. (8, 16). 
    There is little information regarding the introduction of dairy livestock on previously 
unused farm land to study the establishment and proliferation of bacteria of interest in 
microbiology and food safety. Iowa State University (ISU; Ames IA) was awarded 887 acres 
of land by a donor family. ISU constructed an academic teaching farm-the Dairy/Animal 
Science Education Facility (henceforth referred to as the “ISU Dairy Farm”). Prior to the 
establishment of the ISU Dairy Farm, the facility had been used for recreational purposes; no 
production livestock had ever been introduced. A complex of buildings were constructed on 
27 acres of land including a free-stall barn, special needs/hospital barn, maternity barn, and a 
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calf research barn for nutrition and husbandry research. Dairy cattle were placed beginning 
on 26 November 2007; the farm typically houses 450 milking cows plus a similar number of 
heifers, dry cows and calves. Most of the animals were moved from the former ISU teaching 
farm located about 20 miles north of campus (in Ankeny IA). Additionally, 50 cows were 
introduced to the new dairy farm from a dairy center in Calmar, IA.  A map of the dairy farm 
is included in the appendix of this paper. A longitudinal study of antibiotic resistance of 
Campylobacter spp.-specifically resistance to tetracycline, erythromycin and nalidixic acid 
was conducted. Erythromycin (a marcolide) and nalidixic acid (a quinolone) are often 
treatments of choice for human patients with acute campylobacteriosis-particularly those who 
are immunocompromised (6, 46).Tetracycline is sometimes considered as an alternative 
therapy, however antibiotic resistance is now making tetracycline treatment less effective 
(46).  
   Environmental samples were collected at select locations on the facility prior to the 
introduction of livestock in to determine initial antibiotic resistance (if any). All samples 
were immediately processed, screened with Campylobacter Selective Agar-also known as 
“Preston agar” (Oxoid, Cambridge UK), and later replica plated on Tryptic Soy Agar (Becton 
Dickinson Company, Sparks MD) containing a predetermined amount of antibiotic, 
observing for growth of antibiotic resistant colonies. To confirm the presence of 
Campylobacter, colonies were surveyed for hippurate activity (hippurate discs with 
ninhydrin reagent, Remel, Lenxa, KS), Gram stained and analyzed by the Campylobacter 
Test Kit (Oxoid, Cambridge UK). Routine detection of Campylobacter spp. is based on 
culture on selective media and subsequent phenotypic identification (32, 42, 55). The 
sampling process was repeated after dairy cattle were introduced, duplicating the entire 
laboratory process. Dairy farm sampling took place on seven different dates; two prior to 
cattle placement and five after placement (table 1 and page 49) 
Materials and Methods:  
One sterile 3 in x 3 in drag swab moistened with 10 mL skim milk (Solar Biologics, 
Ogdensburg, NY) was used per sample. Briefly, a drag swab was pulled through the 
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  TABLE 1. ISU DAIRY FARM SAMPLING DATES 
Prior to introducing dairy cattle After introducing dairy cattle 
20 October 2007 (A) 27 January 2008 (C) 
13 November 2007 (B) 29 February 2008 (D) 
 12 March 2008 (E) 
 23 April 2008 (F) 
 28 May 2008 (G) 
 
environment for 60 seconds (in later sample collections, efforts were made to duplicate 
sampling locations). Each drag swab was placed in a sterile bag and placed in a cooler kept at 
4º C. After collection, samples were taken to the laboratory and immediately processed; 
researchers noted that the recovery of Campylobacter is reduced by temperature storage at 4º 
C for 24 hours (25). Each drag swab was aseptically added to a sterile Whirl Pack 24 oz/720 
mL filtered homogenizer bag (Nasco, Fork Atkinson, WI).  Ten mL of buffered peptone 
water was added (BPW; Difco, Becton Dickinson Company, Sparks, MD) to moisten sample 
for pipetting. The filtered bag was homogenized for 45 seconds at 250 RPM. One ml of 
sample was then added to a tube containing 9 mL BPW creating a diluent concentration of 10 
-1
. The process was repeated until a diluent concentration of 10-7 was created. A quantity of 
0.1 ml of the 10-2, 10-4, 10-6 and 10-7 diluents were plated on Preston agar with supplement 
(Oxoid, Cambridge UK). Plates were later read as 10-3, 10-5, 10-7 and 10-9.  Preston agar 
incorporates antimicrobial agents (polymyxin, rifampin, trimethoprim and cyloheximide) 
making the media highly selective (32, 42). Plates were incubated for 48 hours at 42 ºC under 
microaerophilic conditions (5 % O2, 5% CO2, 2% H2 and 88% N2 by volume) generated by a 
gas pack (Gas Pak™ EZ, Becton Dickinson Company, Sparks MD).  Populations of 
campylobacter-like colonies were enumerated after incubation. 
    Replica plates were made according to the guidelines of the Clinical and Laboratory 
Standards Institute (CLSI) (54) utilizing Trypitc Soy Agar (TSA). Concentrations of 
antibiotics used (susceptible, intermediate and resistant) were 1.5 times the amount 
recommended by the National Antimicrobial Research Monitoring System (NARMS)a.  
 
aNARMS was established in 1996 by the Food and Drug Administration (FDA) in collaboration with the United 
States Department of Agriculture (USDA) and the Centers for Disease Control and Prevention (CDC).  The 
goals of NARMS include monitoring trends in antimicrobial resistance and foodborne illness, disseminating 
information, and conducting research to further understand antimicrobial resistance (51). NARMS also assists 
the FDA in the approval of safe and effective antimicrobial drugs for animals (51). 
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The CLSI has approved agar dilution as a standard susceptibility testing method for 
Campylobacter (55). 
Table 2: Minimum Inhibitory Concentrations (MICs) of antibiotics used in replica plating 
Antibioticb R= Resistant 
(ug/mL) 
I= Intermediate 
(ug/mL) 
Resistant (ug/mL) 
TSA with 
tetracycline  
 
> 24 ug/mL  
 
   12 ug/mL  
 
    <  6 ug/mL 
 
TSA with 
erythromycin  
 
> 48 ug/mL  
  
 
 
   24 ug/mL  
 
    < 12 ug/mL 
TSA with 
nalidixic acid  
 
> 96 ug/mL  
 
 
 
   48 ug/mL  
 
    <  24 ug/mL  
 
bAntibiotic Resistance 1.5 X NARMS concentrations 
 
    Each Preston agar “master plate” was later replicated using a sterile piece of velvet and a 
replica plating apparatus. Each piece of velvet was lightly pressed onto a series of TSA plates 
containing a specified amount of antibiotic (Table 2). After incubation for 48 hours at 37º C 
under microaerophilic conditions (Gas Pak™ EZ, Becton Dickinson Company, Sparks MD), 
the populations of antibiotic-resistant bacteria were enumerated. Replica plating has been 
shown to be effective with large numbers of environmental samples (40) however, it requires 
a high level of training and expertise (19). Additionally, antibiotic-containing plates have a 
very short shelf-life and require frequent preparation which often takes place in longitudinal 
studies or clinical laboratory settings (19). Therefore antibiotic-containing replica plates were 
prepared and refrigerated 1-2 weeks before farm sampling. All data were analyzed by 
EpiInfo™ Version 3.5.1, a statistical program created by Centers for Disease Control and 
Prevention (Atlanta, GA) at 95% confidence limits. 
Results: 
    Since there were large amounts of data collected, only the populations of resistant bacteria 
at 10-5 concentration were reported (> 24 ug/mL tetracycline, > 48 ug/mL erythromycin and > 
96 ug/mL nalidixic acid). Based on the available data, four locations on the ISU dairy farm 
were examined in more detail, as these had consistent populations of resistant bacteria; the 
maternity and calf barn, solids separator, the free stall barn and the special needs/hospital 
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barn. Overall, there were low populations of antibiotic resistant organisms (measured in 
colony forming units or CFUs) detected prior to cattle introduction (table 3, farm sampling A 
and B). After the introduction of cattle, the numbers of Preston agar “master colonies” and 
the antibiotic resistance colonies demonstrated some variability. However there was an 
overall increase in the populations of the Preston agar plates (table 3, farm sampling C-G). 
This also occurred with the antibiotic resistant plates (table 3, farm sampling C-G).  
    In Tables 4A and 4B, data are presented in graph form using a logarithmic scale. 
Throughout the study, the numbers of erythromycin-resistant CFUs demonstrated a steady 
increase (from log10 6.1 to log10 7.18). The nalidixic acid-resistant CFUs demonstrated 
variability in the numbers of colonies (decrease, increase then gradual increase of bacterial 
growth) from a low of log10 6.3 to a high of log10 7.08. Tetracycline colonies also 
demonstrated some variability (from a low of log10 6.20 to a log10 of 7.48).  
 
Table 3. General farm trends (actual numbers) 
Sampling 
group  
A B C D E F G 
Temperature 
(F/C) 
51/10.6 37/2.8 21/-6.1 36/2.2 38/3.3 56/13.3 49/9.4 
Humidity (%) 83 76 85 70 73 54 64 
Number of 
CFUs* 
(Preston) 
0 2 132 17 213 89 332 
Antibiotic 
resistance 
CFUs (Ery) 
0 0 13 20 53 66 146 
Antibiotic 
resistance 
CFUs (Nal) 
 
0 0 20 3 120 15 78 
Antibiotic 
resistance 
CFUs (Tet) 
 
0 0 94 16 33 52 302 
*CFUs= colony forming units, Ery=Erythromycin, Nal=Nalidixic Acid, Tet=Tetracycline 
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Table 4A. Erythromycin, Nalidixic Acid and Tetracycline Resistance in CFUs  
0
1
2
3
4
5
6
7
8
Log CFU/uL
A B C D E F G
Sampling Period
5 Ery 48
5 Nal 96
5 Tet 24
      
4B. Graph data in Log10 scale 
 A B C D E F G 
5 Ery 48 ----- ----- 6.1 6.3 6.7 6.82 7.18 
5 Nal 96 ----- ----- 6.3 5.47 7.08 6.2 6.89 
5 Tet 24 ----- ----- 6.97 6.20 6.52 6.72 7.48 
Ery=Erythromycin, Nal=Nalidixic Acid, Tet=Tetracycline 
 
Table 5. Resistance profile and number of CFUs-Campylobacter isolates (n=15) 
Location Number of 
antibiotics 
Resistance 
profile 
Ery 48 Nal 96 Tet 24 
F8 1 Ery 48  1 0 0 
C8 2 Ery 48 Tet 24 5 0 43 
C 15 2 Ery 48 Tet 24 2 0 5 
D 10 2 Ery 48 Tet 24 17 0 13 
E 8 2 Ery 48 Ter 24 20 0 12 
F15 2 Ery 48 Tet 24 9 0 5 
E 11 2 Ery 48 Tet 24 17 88 0 
G 11 2 Ery 48 Tet 24 6 0 4 
C 11 3 Ery 48 Nal 96  
Tet 24 
6 20 46 
D 15 3 Ery 48 Nal 96  
Tet 24 
3 3 3 
E 10 3 Ery 48 Nal 96  
Tet 24 
16 32 21 
F 10 3 Ery 48 Nal 96  
Tet 24 
50 13 39 
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Table5.(continued)      
Location Number of 
antibiotics 
Resistance 
profile 
Ery 48 Nal 96 Tet 24 
F 11 3 Ery 48 Nal 96  
Tet 24 
6 2 8 
G 10 3 Ery 48 Nal 96  
Tet 24 
48 70 73 
G 15 3 Ery 48 Nal 96  
Tet 24 
92 8 225 
 
Of the 28 sample locations (table 5), 13 had no antibiotic resistance profile (all A and B 
sampling locations, D8, D11, and E15 which are not included in table 5). In one sampling 
location (F8, the maternity/calf barn), resistance was detected to one antibiotic 
(erythromycin).  Resistance to two antibiotics (erythromycin and tetracycline) were detected 
in 7 locations; C8 and E8, (the maternity/calf barn and free stall barn); D10, the solids 
separator; E11 and G 11 (free stall barn); as well as C15 and F15, the hospital/special needs 
barn).  Resistance to all three antibiotics (erythromycin, nalidixic acid and tetracycline) 
occurred at locations E10, F10, and G10 (solids separator), C11 and F11 (free stall barn) as 
well as D15 and G15 (hospital and special needs barn).  In order to review individual 
changes in sampling groups over time, the location and number of antibiotic-resistant profiles 
were diagrammed. (table 6)  
Table 6. Locations and antibiotic resistance profiles  
Sample (time) Zero Resistance to 1 
antibiotic 
Resistance to 2 
antibiotics 
Resistance to 3 
antibiotics 
A8 A8 (MC)    
A10 A10 (SS)    
A11 A11 (FSB)    
A15 A15 (HSN)    
B8 B8 (MC)    
B10 B10 (SS)    
B11 B11 (FSB)    
B15 B15 (HSN)  C8 (MC)  
C8     
C10        C 10X    
C11    C11 (FSB) 
C15   C15 (HSN)  
D8 D8 (MC)    
D10   D10 (SS)  
D11 D11 (FSB)    
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Table 6. (continued) 
Sample (time) Zero Resistance to 1 
antibiotic 
Resistance to 2 
antibiotics 
Resistance to 3 
antibiotics 
D15    D15 (HSN) 
E8   E 8 (MC)  
E10    E10 (SS) 
E11   E11 (FSB)  
E15      E15 X    
F8  F8 (MC)   
F10    F10 (SS) 
F11    F11 (FSB) 
F15   F15 (HSN)  
G8          G8 X    
G 10    G10 (SS) 
G11   G11 (FSB)  
G15    G15 (HSN) 
 N=13 N=1 N=7 N=7 
MC=Maternity/Calf barn   SS=Solids Separator    FSB=Free Stall barn     HSN=Hospital/Special Needs  X= 
TNTC (Too Numerous To Count ) 
 
All of the A and B samples had an antibiotic profile of zero (prior to introduction of dairy 
cattle). The C samples varied from an antibiotic profile of 2 (C15, the special needs/hospital 
barn) to an antibiotic profile of 3 (C11, Free Stall barn). No antibiotic resistance was detected 
in locations D8 and D11 (maternity/calf barn and free stall barn, respectively). However in 
locations C15 and D10 (the solids separator and hospital/special needs barn) there were 
antibiotic profiles of 2. In the E sampling group, locations E8, E10 and E11 (the 
maternity/calf barn, solids separator, and free stall barn) had a resistance of profile of 2 or 3 
(table 6).  All locations in the F group had an antibiotic resistance profile. The location of F8 
(solids separator) had an antibiotic resistance profile of 1; location F15 (the hospital/special 
needs barn, respectively) had a resistance profile of two. F10 and F11 (the solids separator 
and free stall barn) had an antibiotic profile of 3. Location G11 (free stall barn) had an 
antibiotic profile of 2, and locations G10 and G15 (the solids separator and hospital/special 
needs barn, respectively) had an antibiotic profile of 3. Table 7 depicts the percentages of 
antibiotic resistant colonies per sampling location. Each location is listed according to the 
resistance (R) profile-therefore all locations having a “zero” profile are grouped together, 
those with an antibiotic resistance profile of 1 are grouped together, and so on. Additionally, 
the numbers of total colonies grown on each Preston Agar “master plate” versus the 
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percentage of colonies that grew on antibiotic-containing replica plates were determined 
(table 7). 
Table 7: Percentage of antibiotic resistant colonies 
Farm 
Location 
ID 
Number R* 
COP 
**P Ery48 **P Nal96 **P Tet 24 Locations 
A 8 0 0 0 0 0 Maternity/calf 
barn 
A 10 0 0 0 0 0 Solids 
separator 
A 11 0 0 0 0 0 Free stall barn 
A 15 0  0 0 0 Special/hospital 
B 8 0 0 0 0 0 Maternity/calf 
barn 
B 10 0 0 0 0 0 Solids 
separator 
B 11 0 0 0 0 0 Free stall barn 
B 15 0 0 0 0 0 Special/hospital 
D 8 0 0 0 0 0 Maternity/calf 
barn 
D 11 0 0 0 0 0 Free stall barn 
G 11 0 128 5 0 14 Free stall barn 
F 8 1 8 13 0 0 Maternity/calf 
barn 
C 15 2 28 9 0 23 Special/hospital 
D 10 2 10 170 0 130 Solids 
separator 
E 8 2 45 44 0 27 Maternity/calf 
barn 
E 11 2 108 16 81 0 Free stall barn 
F 15 2 28 32 0 18 Special/hospital 
G 11 2 128 5 0 14 Free stall barn 
C 11 3 10 10 33 77 Free stall barn 
D 15 3 7 43 43 43 Special/hospital 
E 10 3 60 27 53 35 Solids 
separator 
F 10 3 43 116 30 91 Solids 
separator 
F 11 3 10 60 20 80 Free stall barn 
G 10 3 60 80 117 122 Solids 
separator 
G 15 3 144 64 6 156 Special/hospital 
C 10 TNTC TNTC TNTC TNTC TNTC Solids 
separator 
E 15 TNTC TNTC TNTC TNTC TNTC Special/hospital 
G 8 TNTC  TNTC TNTC  TNTC  TNTC  Maternity/calf 
barn 
COP=colonies on each Preston plate TNTC= Too Numerous To Count *R=Number resistance profile **P= 
percent 
.  
Medical Treatment and Sanitizers Used 
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Medications were used to treat conditions such as mastitis, bovine respiratory disease and 
wound infections (tables 9A and 9B). The medications were prescribed by an ISU faculty 
veterinarian who disclosed uses and dosages given.  Ill cattle were separated and treated 
individually (there were no group treatments). In addition, detailed protocols of treatment 
regimens were strictly followed. 
 
Table 8A: List of antibiotics used on the ISU Dairy Farm (name, class, and mode of action)  
Antibiotic(s) Class  Treatment(s) Mode of action (2, 7, 8, 
33, 53) 
Liquamycin  Tetracycline Pneumonia 
(shipping fever), 
scours, wound 
infections 
Inhibits protein 
synthesis 
Draxxin, Tylan Marcolide Draxxin-Bovine 
Respiratory Disease 
Tylan-shipping 
fever, pneumonia, 
foot rot, calf 
diphtheria 
Inhibits protein 
synthesis 
Nuflor Chloramphenicol Bovine Respiratory 
Disease 
Inhibits protein 
synthesis 
Pirsue Lincosamide Clinical and subclinical 
mastitis 
Inhibits protein 
synthesis 
Excenel, Spectramast LC, 
Spectramast DC,  Naxcel 
Cephalosporin Clinical and subclinical 
mastitis 
Inhibits cell wall 
synthesis 
Polyflex Penicillin Broad spectrum 
antibiotic, shipping 
fever, pneumonia 
Inhibits cell wall 
synthesis 
 
Table 8B: Additional medications used on the ISU Dairy Farm 
Medication Purpose 
Banamine Non-Steroidal Anti-Inflammatory Drug 
Sterile Saline, Hypertonic Saline Solution Intravenous therapy  
 
BAC-STOP udder predip (Esteam Manufacturing Ltd., Calgary, Alberta) and Transcend 
udder postdip (IBA, Millbury, MA.) were used as sanitizers prior to and after milking. FC-98 
Udder Wash (IBA, Millbury, MA.) was also used a boot sanitizer.  
Discussion 
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  It appears that the length of time cattle were housed at the ISU Dairy Farm directly 
correlated to the detection of antibiotic resistance in on the ISU dairy farm; more so than 
changes in farm temperature and humidity (although this was a 9-month study). Even though 
there were variability in the populations of Campylobacter detected on Preston agar and on 
the antibiotic-containing TSA agar plates (nalidixic acid and tetracycline), the number of 
CFUs present on Preston and TSA plates increased overall (table 3). There were also sizeable 
increases in the populations of antibiotic-resistant bacteria that grew on antibiotic-containing 
plates between sampling locations F and G (table 3). 
    When reviewing antibiotic resistance profiles (table 5), 7 out of 15 locations (47%) 
possessed the Ery48 Nal96 Tet24 resistance profile and 7 out of 15 locations (47 %) 
possessed the Ery48 Tet24 profile. The MDR profiles began to appear during sampling group 
C (27 January 2008) after dairy cattle placement. When the resistance profiles were viewed 
according to sampling date (e.g. all A samples were graphed together, all B samples were 
grouped together, and so on; table 6), there was a general trend toward MDR as time 
progressed. Multi-drug resistance (2 agents, n=7) were divided between the maternity/calf 
barn (location #8), the solids separator (location # 10), the free stall barn (location # 11) and 
the hospital/special needs barn (location # 15).  Resistance to three antibiotics tested (n=7) 
included the solids separator (location # 10), the free stall barn (location # 11) and the 
hospital/special needs barn (location # 15). Also, several sampling locations had TNTC totals 
(C10, solids separator; E15, hospital/special needs barn; and G8, maternity/calf barn; table 
8); it is probable that multidrug resistance could have been detected at those sampling 
locations. 
    When examining the percentages of antibiotic resistance (when compared to the initial 
Preston plate colony counts), there was some variability, but percentages increased with 
progression of time (Table 7). For example, when examining location # 10 (solids separator), 
no bacterial populations were detected in either A and B sampling periods. However, in 
sampling period C, a TNTC plate was detected. In summary, the percentages of antibiotic-
resistant populations increased once production animals were introduced to the facility. 
Conclusions 
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    The prevalence of antibiotic resistance in Campylobacter has fluctuated in various studies. 
In a 1999-2000 study of antimicrobial resistance patterns of Campylobacter from feedlot 
cattle, 51.6 %, 12.1% and 0.9% of isolates (C. jejuni and C. coli) were resistant to 
tetracycline, nalidixic acid and erythromycin, respectively (14). This study focused on 
feedlots with 1000 head or higher (which held over 80% of US dairy cattle as of 1999). In a 
2001 survey of lactating dairy cattle (720 cows from farms in the Northeast, Pacific and 
Southwestern United States), a lower overall prevalence of antibiotic resistance was 
determined; 53% of isolates were resistant to tetracycline, but isolates were susceptible to 
other antibiotics (including erythromycin and ampicillin) (22). In a 2006 survey, fecal 
samples were taken from 1435 dairy cows (representing 96 dairy operations in 21 US states) 
(15). Of the 735 Campylobacter isolates tested, 49.4% were resistant to tetracycline, 4.5 % 
were resistant to nalidixic acid and 1.3% were resistant to erythromycin. In this study, it is 
important to recall that the amounts of antibiotics used in making TSA replica plates were 1.5 
times the NARMS amount stated for antibiotic resistance; e.g. antibiotic-resistant CFUs 
formed on plates containing very high amounts of antibiotics. Other studies have also utilized 
higher MIC breakpoints than cited by NARMS in determining antibiotic resistance (53). This 
is the first study to our knowledge that studied the establishment and proliferation of bacteria 
(of interest in microbiology and food safety) before and after the introduction of production 
livestock. Prior to cattle placement, the numbers of Campylobacter identified as well as 
antibiotic resistance profiles were low. However, the numbers of detected Campylobacter 
increased once production animals were introduced to the facility. Additionally resistance to 
one (or multiple) antibiotics was detected immediately after production animal placement.  
    Caution should be used when comparing prevalence between studies due to factors such as 
differences in microbiological culture methods and sampling protocols (10). For example in 
one study, environmental samples were transported for laboratory analysis within 24 hours of 
collection (22) while in this study, environmental samples were immediately processed after 
collection and transport to the lab (all materials needed for experiments were organized prior 
to collection). In addition, there were large amounts of samples collected over an extended 
period of time in some research (15) while other studies collected fewer samples over a 
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shorter period of time (22). Duration of sample collection periods varied; some were short 
(22) while other collection periods covered several years (14). 
     Longitudinal studies are important in providing insight into the dynamics of endemic 
diseases of dairy herds (44). A detailed understanding of topics such as the infection process 
and mechanisms for persistence are essential to controlling infections and lowering their 
prevalence in dairy cattle (44). A study by Pradham et al. (2009) reviewed the prevalence of 
Campylobacter in fecal samples collected from dairy cows on three farms in the states of 
New York, Vermont and Pennsylvania. Samples were taken seven times in a 30 month 
period (from Feb 2004 to May 2007). The range of Camplyobacter spp. varied from a low of 
0% to a high of 80.8%. The study was important in demonstrating different prevalence of 
zoonotic pathogens (such as Campylobacter) within and between farms (44). It is believed 
that factors such as farm management, genetics, nutrition, hygiene and manure management 
practices may be involved (44). In this longitudinal study, there was also some variation 
which may be related to previously mentioned factors. Continued monitoring of pathogens 
such as antibiotic resistance Campylobacter is important in reducing the prevalence of 
infections in animals and in humans. 
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Appendix: The Iowa State University's Dairy/Animal Science Education and Discovery 
Facility 
 
 
 
1) Feed Storage Area (FSA)    11) Free Stall Barn (FS11) 
2) Open Field NE (OF)        12) Free Stall Barn (FS12) 
3) Heifer Barn 9-15 months (H9)       13) Free Stall Barn Walkway (FW) 
4) Heifer Barn 2-8 months (H2)      14) Holding Area Walkway (HW) 
5) Heifer Barn 16-22 months (H16)      15) Holding Area/Milking (HM) 
6) Maternity/Calf Barn (MC 6)       16) Special Needs/Hospital Barn (SH) 
7) Maternity/Calf Barn (MC 7)     17) Parking Main Entrance (PM) 
 8) Maternity/Calf Barn (MC 8)      18) Parking/Employee/Showers (PS) 
9) Dry Cow/Transition Barn (DC)       19) Equipment Storage (ES) 
10) Solids Separator (SS)    20) Machine Storage Area (MS) 
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A longitudinal study of the establishment and proliferation of Enterococcus on a Dairy 
Farm 
 
Ginger M. Shipp and James S. Dickson 
Abstract 
Enterococci are Gram-positive, facultative anaerobic cocci. They occur in a remarkable array 
of environments, because of their ability to grow and survive under harsh conditions (22). 
Enterococci are also found in a large variety of foods including milk and dairy products, 
vegetables, plants, cereals and meats.  Enterococcus spp. are considered commensal 
organisms, but can also be opportunistic pathogens associated with morbidity and mortality 
of humans and animals. There is little information regarding the introduction of dairy 
livestock (and bacterial organisms) on previously unused farm land. A longitudinal study of 
antibiotic resistance of Enterococcus (to ampicillin, erythromycin and tetracycline) was 
conducted on an academic teaching farm. Environmental samples were collected by drag 
swabs at select locations prior to and after the introduction of livestock to determine 
antibiotic resistance. All samples were initially processed and screened with specialized 
media (Enterococcosel agar) then later replica plated on Tryptic Soy Agar (TSA) containing 
a predetermined amount of antibiotic.  Both the numbers and the percentages of bacterial and 
antibiotic-resistant colonies increased as cattle were placed at the facility. Most antibiotic 
profiles of resistant organisms that grew on 10-3 TSA plates had the profile of combined 
erythromycin and tetracycline resistance. There were no Too Numerous to Count (TNTC) 
Enterococcosel agar plates prior to dairy cattle placement. However after cattle placement, 
TNTC plates began to appear. The numbers of TNTC plates were not time-dependant and 
appeared consistently in sampling periods C-G (after placement of cows). There is little 
information on the prevalence and epidemiology of antibiotic resistance of Enterococci 
outside of the hospital setting, including on dairy farms.  In this (and other studies cited), the 
percentage of antibiotic resistance varied. Longitudinal studies are important in providing 
insight into the dynamics of establishment and proliferation of bacteria and of antibiotic 
resistance.  
 
Key words: longitudinal study, dairy farm, ampicillin, erythromycin, tetracycline, drag 
swabs, replica plating, NARMS, CLSI. 
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  Enterococci are Gram-positive, facultative anaerobic cocci that occur singly, in pairs or as 
short chains (16). The term ‘enterococcus’ originates from the Greek enteron meaning ‘the 
gut or intestines’ and kokkos meaning ‘a berry or kernel’ (33). The enterococci as a group 
were first described by Thiercelin (1899) and the genus Enterococcus was proposed by 
Thiercelin and Jouhaud (1903) for Gram-positive diplococci of intestinal origin (13). 
Enterococci were later placed in the genus Streptococcus in the 1930s, with the establishment 
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of the Lancefield serological typing system (22). The genus Enterococcus was described by 
Shleifer and Kilpper-Bälz (1984) who demonstrated that Streptococcus faecalis and 
Streptococcus faecium were distinct enough from other streptococci to warrant their transfer 
to the genus Enterococcus (13). Enterococcus is member of the lactic acid bacteria (LAB) 
group of organisms. LABs are found in a large variety of foods including milk and dairy 
products, vegetables, plants, cereals and meats. LAB are used to manufacture and preserve 
foods or deliberately added as “starter cultures” in order to execute the fermentation process 
(13, 29). Enterococcus are also used as probiotics (cultures of live microorganisms which, 
when given to animal or humans, beneficially affect the hosts by improving properties of 
indigenous flora) (13). There is some controversy regarding the use of Enterococcus in food 
products. Unlike other LAB, enterococci are not considered “Generally Recognized as Safe” 
(or GRAS) organisms because they are considered emerging pathogens, are sometimes 
implicated in food spoilage, and can indicate fecal contamination (30). 
     Enterococci occur in a remarkable array of environments, because of their ability to grow 
and survive under harsh conditions They are considered commensal organisms, but can also 
be opportunistic pathogens associated with significant morbidity and mortality of humans 
and animals (27). They usually cause infections in patients who have severe underlying 
disease, are immunocompromised, or are elderly (15, 30). In the mid 1980s, reports of high-
level vancomycin resistance were documented, particularly in hospitals (21, 33). Mortality is 
generally high (from 42-68%) in patients with enterococcal bacteremia and usually occur in 
persons who are debilitated, have underlying disease or have received medical 
instrumentation (13, 27, 43). 
    Enterococci can cause many economically important veterinary diseases such as bovine 
mastitis and diarrhea (16, 35).  Mastitis in cattle causes significant losses in the dairy industry 
(44) causing cows to produce less milk,  produce milk that can not be sold, or cause farmers 
to cull sick cows rather than treat them due to the cost of treatment (17).  The epidemiology 
of Enterococcus in bovine mastitis has not been totally clarified but enterococci are generally 
associated with infections related to poor hygiene (16).  
    There is little information regarding the introduction of dairy livestock on previously 
unused farm land to study the establishment and proliferation of bacterial organisms of 
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interest in microbiology and food safety. Iowa State University (ISU; Ames IA) was awarded 
887 acres of land by a donor family. ISU constructed an academic teaching farm-the 
Dairy/Animal Science Education Facility (henceforth referred to as the “ISU Dairy Farm”). 
Prior to the establishment of the facility, it had been used for recreational purposes; no 
livestock had ever been introduced. A complex of buildings were constructed on 27 acres 
including a free-stall barn, special needs/hospital barn, maternity barn, and a calf research 
barn for nutrition and husbandry research. Dairy cattle were introduced on the facility 
beginning on 26 November 2007; the farm typically houses 450 milking cows plus a similar 
number of heifers, dry cows and calves. Most of the animals were moved from the former 
ISU teaching farm located about 20 miles north of campus (in Ankeny IA). Additionally, 50 
cows were introduced to the new dairy farm from a dairy center in Calmar, IA. A map of the 
dairy farm is included in the appendix of this paper.  
    It was decided to conduct a longitudinal study of antibiotic resistance of Enterococcus 
spp.-specifically resistance to ampicillin, erythromycin and tetracycline. Ampicillin is the 
first aminopenicillin introduced into clinical use (28) and is one of the most prescribed 
antibiotics in the world (4). Ampicillin (along with penicillin) is indicated for enterococcal 
infections other than endocarditis in non-allergic cases (16). Erythromycin (a marcolide) has 
a broad spectrum and is active in vitro against most Gram-positive and some Gram negative 
bacteria (28), however reported marcolide resistance among enterococci from non-human 
sources have been noted in several studies (16). The tetracyclines were once widely used to 
treat bacterial infections (including Enterococcus), however, use has declined as the 
incidence of acquired bacterial resistance has increased and there are currently more active 
and better tolerated antimicrobial agents (12, 23). 
Materials and Methods 
    Environmental samples were collected at select locations on the ISU Dairy Farm prior to 
the introduction of livestock in order to determine initial antibiotic resistance (if any). All 
samples were immediately processed, screened with specialized media (Enterococcosel Agar, 
Becton Dickinson Company, Sparks MD)a, and later replica plated on Tryptic Soy Agar 
(Becton Dickinson Company, Sparks MD) containing a predetermined amount of antibiotic, 
observing for growth of antibiotic resistant colonies. (8). The sampling process was repeated 
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after dairy cattle were introduced, duplicating the entire laboratory process. Dairy farm 
sampling took place on seven different dates; two prior to cattle placement and five after 
Placement (table 1) 
Table 1. ISU Dairy Farm Sampling Dates 
Prior to introducing dairy cattle After introduction of dairy cattle 
20 October 2007 (A) 27 January, 2008 (C) 
13 November 2007 (B) 29 February 2008 (D) 
 12 March 2008 (E) 
 23 April 2008 (F) 
 28 May 2008 (G) 
     
    One sterile 3 cm x 3 cm drag swab moistened with 10 mL skim milk (Solar Biologics, 
Ogdensburg, NY) was used per sample. Briefly, a drag swab was pulled through the 
environment for 60 seconds (in later collections, efforts were made to repeat sampling from 
previously examined locations). Each drag swab was placed in a sterile bag and stored in a 
cooler kept at 4º C. After collection, samples were taken to the laboratory and immediately 
processed. Each drag swab was aseptically added to a sterile Whirl Pack 24 oz/720 mL 
filtered homogenizer bag (Nasco, Fork Atkinson, WI).  Ten mL of buffered peptone water 
was added (BPW; Difco, Becton Dickinson Company, Sparks, MD) to moisten sample for 
pipetting. The filtered bag was homogenized for 45 seconds at 250 RPM. One ml of sample 
was then added to a tube containing 9 mL BPW and creating a diluent concentration of 10 -1. 
The samples were serially diluted until a concentration of 10-7 was created. A quantity of 0.1 
ml of the 10-2, 10-4, 10-6 and 10-7 diluents were plated on Enterococcosel agar.  Plates were 
incubated for 48 hours at 37 ºC.  Colonies on each plate were later read as 10-3, 10-5, 10-7 and 
10-8 after incubation populations of Enterococcus were enumerated after incubation.  
   Replica plates were made according to the guidelines of the Clinical and Laboratory 
Standards Institute (CLSI) (47) utilizing Tryptic Soy Agar (TSA).  Tetracycline plates  
(susceptible, intermediate and resistant) were made at 1.5 times the amount recommended by 
 
aEnterococcosel agar relies on the inhibitory properties of oxgall (a concentrated bile salt) against Gram-positive 
organisms other than Enterococci (8, 49). The growth of Gram-negative species are reduced by sodium azide 
(8, 49). Esculetin reacts with an iron salt, ferric ammonium citrate, to form a dark brown or black complex (49). 
Enterococci produce brown-black zones beneath brown-black colonies. 
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the National Antimicrobial Research Monitoring System (16). Ampicillin plates were also 
made 1.5 times the NARMS standards for susceptible and resistant concentrations (12 and 24 
ug/mL, respectively).  Enterococci is becoming increasingly resistant to ampicillin (40) 
therefore, TSA plates containing 48 ug/mL of ampicillin were included in this study. 
Enterococcus is considered broadly resistant to erythromycin (3) therefore, TSA plates 
containing (higher) intermediate and resistant concentrations of erythromycin (6 and 12 
ug/mL, respectively) were also used.  
     
Table 2. Concentrations of antibiotics used in replica plating  
   Resistant  Intermediate    Susceptible 
TSA with 
ampicillin 
 
> 48 ug/mL  
 
   24 ug/mL  
 
    <  12 ug/mL 
 
TSA with 
erythromycin  
 
> 48 ug/mL  
  
 
 
   12 ug/mL  
 
    < 6 ug/mL 
TSA with 
tetracycline 
 
> 24 ug/mL  
 
 
 
   12 ug/mL  
 
    <  6 ug/mL  
 
 
   Each Enterococcosel agar “master plate” was later replicated using a sterile piece of velvet 
and a replica plating apparatus. A single piece of velvet was pressed onto a series of TSA 
plates containing a specified amount of antibiotic (table 2). After incubation for 24 hours at 
37º C under aerobic conditions, the populations of antibiotic-resistant bacteria were 
enumerated. Replica plating is effective with large numbers of environmental samples (32) 
however, it requires a high level of training and expertise (19). Antibiotic-containing plates 
have a very short shelf-life and require frequent preparation-which often takes place in 
longitudinal studies or clinical laboratory settings (19). Therefore antibiotic-containing 
replica plates were prepared and refrigerated 1-2 weeks before sampling. All data were 
analyzed by EpiInfo™ Version 3.5.1, a statistical program created by Centers for Disease 
Control and Prevention (Atlanta, GA) at 95 % confidence interval. 
 
Results 
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Since there were large amounts of data collected, only the populations of “resistant” bacteria 
(10-3 and 10-5) were reported (> 24 ug/mL tetracycline, > 48 ug/mL erythromycin and > 48 
ug/mL ampicillin).  The dairy farm locations are diagrammed below in table 3 and on page 
67.  
 
 Table 3. ISU Dairy Farm Sampling Locations                      
1) Feed Storage Area (FSA) 11) Free Stall Barn (FS 11) 
2) Open Field NE (OF) 12) Free Stall Barn (FS 12) 
3) Heifer Barn 9-15 months (H9) 13) Free Stall Barn Walkway (FW) 
4) Heifer Barn 2-8 months (H2) 14) Holding Area Walkway (HW) 
5) Heifer Barn 16-22 months (H16) 15) Holding Area Milking (HM) 
6) Maternity/Calf Barn (MC 6) 16) Special Needs/Hospital Barn (SH) 
7) Maternity/Calf Barn (MC 7) 17) Parking Main Entrance (PM) 
8) Maternity/Calf Barn (MC 8) 18) Parking/Employee/Showers (PS) 
9) Dry Cow/Transition Barn (DC) 19) Equipment Storage (ES) 
10)  Solids Separator (SS) 20) Machine Storage Area (MS) 
 
When assessing ampicillin concentration (48ug/mL) and antibiotic resistance, the numbers of 
CFUs growing on 10-3 TSA plates were as follows: 
 
Table 4. Total colonies and ampicillin-resistant colonies (10-3) 
Farm 
Location  
Log10 values 
(total 
colonies) 
Total 
colonies 
(E)* 
Log10 Values 
(CFUs 
Resistance*) 
CFUs 
Resistance* 
Percentage  
A 1.38 24 0 1 4 % 
B 1 10 0.70 5 50 % 
C 2.15 142 1.38 24 17 % 
D 2.35 227 2.36 4 2 % 
E 2.60 407 2.15 142 35 % 
F 2.10 127 1.20 16 13 % 
G 1.91 82 --- 0  0 % 
* CFUs Resistant= grown on TSA with antibiotic    E=Enterococcosel Agar 
 
 
Resistance ranged from none detected (G) to 50% (B). In examining the numbers of 
Enterococcus colonies and erythromycin resistance: 
 
Table 5. Total colonies and erythromycin-resistant colonies (10-3) 
Farm Group Log10 values 
(total 
colonies) 
Total 
Colonies 
(E)* 
Log10 
Values 
(CFUs 
Resistance*) 
CFUs 
Resistance 
* 
Percentage  
A 1.38 24 --- 0 0 % 
B 1 10 1.54 35 350 % 
C 2.15 142 1.20 16 11 % 
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Table 5. (continued) 
D 2.35 227 1.84 70 31 % 
E 2.60 407 2.29 196 48 % 
F 2.10 127 1.73 54 42 % 
G 1.91 82 0.48 3 4 % 
* CFUs Resistant= grown on TSA with antibiotic    E=Enterococcosel Agar 
 
Resistant colonies that grew on TSA containing erythromycin ranged from none (A) to 350 
% (B).  
    When identifying numbers of tetracycline-resistant colonies during the study, there were 
no resistant colonies detected before dairy cattle introduction. However, after cattle 
introduction, the percentages of resistant colonies growing on antibiotic-containing TSA 
plates were high-ranging from 74 % (G) to 183 % (F): 
 
Table 6.Total colonies and tetracycline-resistant plates (10-3) 
Farm Group Log10 values 
(total 
colonies) 
Total Colonies 
(E)* 
Log10 Values 
(CFUs 
Resistance*)  
CFUs 
Resistant*  
Percentage  
A 1.38 24 --- 0 0 % 
B 1 10 --- 0 0 % 
C 2.15 142 2.10 126 89 % 
D 2.35 257 2.40 249 97 % 
E 2.60 407 2.52 338 83 % 
F 2.10 127 2.36 232 183 % 
G  1.91 82 1.79 61 74 % 
* CFUs Resistant= grown on TSA with antibiotic    E=Enterococcosel Agar     
             
When examining 10-5 concentrations of dairy farm diluents, the total number of CFUs 
detected were lower overall (see diagrams). Antibiotic resistant colonies were also lower 
overall-except for tetracycline: 
Table 7. Ampicillin 48 ug/mL (10-5) 
Farm Group  Log10 
values 
(total 
colonies) 
Total 
Colonies (E)* 
Log10 Values 
(CFUs 
Resistance*)  
CFUs 
Resistant* 
Percentages  
A --- 0 --- 0 0 % 
B --- 0 --- 0 0% 
C 1.89 77 0.30 2 3 % 
D 1.62 42 0 0 0 % 
E 1.46 29 0 1 3 % 
F 1.76 58 0 0 0 % 
G 1.28 60 0 0 0 % 
* CFUs Resistant= grown on TSA with antibiotic    E=Enterococcosel Agar 
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Table 8. Erythromycin 48 ug/mL (10-5) 
Farm Group Log10 values 
(total 
colonies) 
Total Colonies 
(E)* 
Log10 
Values 
(CFUs 
Resistance*) 
CFUs 
Resistant* 
Percentages  
A --- 0 --- 0 0 % 
B --- 0 --- 0 0 % 
C 1.89 77 1.26 18 23 % 
D 1.62 42 1.26 18 43 % 
E 1.46 29  0.60 4 14 % 
F 1.76 58 1.58 38 66 % 
G 1.28 19 1.78 60 32 % 
* CFUs Resistant= grown on TSA with antibiotic    E=Enterococcosel Agar 
 
Table 9. Tetracycline 24 ug/mL (10-5) 
Farm Group Log10 values 
(total 
colonies)Total 
Colonies (E)* 
Total Colonies 
(E)* 
Log10 Values 
(CFUs 
Resistance*) 
CFU 
Resistant* 
Percentages  
A --- 0 ---  0 0 % 
B --- 0 --- 0 0 % 
C 1.89 77 2.12 133 172 % 
D 1.62 42 1.62 42 100 % 
E 1.46 29 1.68 48 166 % 
F 1.76 58 2.34 223 384 % 
G 1.28 60 2.12 132 220 % 
* CFUs Resistant= grown on TSA with antibiotic    E=Enterococcosel Agar 
 
It was interesting to note in the 10-5 group, antibiotic resistance was not detected before 
placement of dairy cattle (keep in mind that resistance was detected in some of the 10-3 
diluent samples prior to the introduction of dairy livestock). Also of note, even though the 
numbers of CFUs formed on Enterococcsel agar were lower (as expected, when compared to 
10-3 diluent concentration), the percentages of colonies resistant to tetracycline remained 
high.  
  The antibiotic profiles of both 10-3 and 10-5 dilutions were examined in detail. The data 
were analyzed and placed in tables (tables 10 and 11) for ease of interpretation. 
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Table 10. Summary of antibiotic-resistance profiles 10-3 dilutions 
Antibiotic 
Profile  
Ery48 Amp48 
Tet 24 (3) 
Antibiotic 
Profile  
Ery48 Amp48 
(2) 
Antibiotic 
Profile  
Amp48 Tet24 
(2) 
Antibiotic 
Profile 
Ery48 
Tet24 (2) 
Antibiotic 
Profile 
Amp48 
(1) 
Antibiotic 
Profile 
Ery48 (1) 
Antibiotic 
Profile Tet 
(1) 
C14, C18, D7, 
D16, F8 
B12 F3 C6, D2, 
D3, D4, 
D8, D9, 
D11, E6, 
E7, E9, 
E18, E20, 
F1, F5, F6, 
F7, F16, 
G9 
A6, B15, 
E5 
B13 C1 C4, 
C9, C17, 
E1, E8, 
G2, G5, 
G7 
 
 
Table 11. Summary of antibiotic-resistance profiles 10-5 dilutions 
Antibiotic Profile  
Ery48 Amp48 Tet24 (3) 
Antibiotic Profile  
Amp48 Tet24 (2) 
Antibiotic Profile  
Ery48 Tet24 (2) 
Antibiotic 
Profile 
Tet24 (1) 
C16, E3 F10, F12, F13, F14, F15, 
G10, G12, G13, G14 
C10, C13, C14, D10, D14, 
D15, E10, E11 
C12, C15, D7, 
D8, D13, E9 
 
The majority of isolates plated on TSA with tetracycline grew (which is consistent with the 
high amounts of antibiotic resistance in table 9).  
    When examining the numbers of antibiotic-resistance colonies on Enterococcsel agar, it is 
important to consider plates too numerous to count (TNTC). Below is a table citing where 
TNTC plates were found (farm group and farm number);  
Table 12: TNTC Locations 
 Location 
A 
Location 
B 
Location 
C 
Location 
D 
Location 
E 
Location 
F 
Location 
G 
N=number 
1 (FSA)       X 1 
2 (OF)   X     1 
3 (H9 )        0 
4 (H2)        0 
5 (H16)        0 
6 (MC 6)    X    1 
7 (MC 7)        0 
8 (MC 8)   X X   X 3 
9 (DC)        0 
10 (SS)   X X X X X 5 
11 (FS 
11) 
  X   X X X 4 
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Table 12. (continued) 
 Location 
A 
Location 
B 
Location 
C 
Location 
D 
Location 
E 
Location 
F 
Location 
G 
N=number 
12 (FS 
12) 
  X X X X X 5 
13 (FW)   X X X X X 5 
14 (HW)   X X  X X 4 
15 (HM)   X X X X  4 
16 (SH)     X   1 
17 (PM)        0 
18 (PS)        0 
19 (ES)        0 
20 (MS)        0 
N 
(group) 
0 0 8 7 6 6 7 34 
 
Medical Care and Sanitizers  
Dairy cattle who presented with medical conditions such as diarrhea, upper respiratory 
disease, or general weakness were reported to farm administrators and treated according to 
the directives of the farm veterinarian.  Additionally, the farm veterinarian made frequent 
“rounds” on the dairy farm to personally assess animal condition. During meetings with the 
dairy farm staff and the veterinarian, protocols were used that detailed the care (and isolation, 
if necessary) of sick cattle. A summary of medications used are included in table 13. It is 
important to note that there was no “group treatment” of animals; each sick cow was treated 
individually.  
Table 13: Medications used on the ISU Dairy Farm 
Medication Medical conditions Class of Drug (1, 6, 28, 46) 
Penicillin SQ Navel infection, foot rot β-lactam 
Excenel Navel infection, diarrhea, 
pneumonia, metritis, foot rot, 
mastitis,  
β-lactam 
Nuflor SQ Pneumonia, upper respiratory 
disease 
chloramphenicol 
Draxxin SQ Upper respiratory disease, 
pneumonia 
Marcolide 
Sulfadimethoxine Pneumonia, upper respiratory 
disease 
Sulfonamide 
Oxytetracycline Pneumonia, foot rot, hairy wart Tetracycline 
Polyflex Metritis β-lactam 
Spectramast LC Mastitis β-lactam 
Fluniximine IV Pneumonia, upper respiratory 
disease 
Non-steroidal Anti-inflammatory 
drugs (NSAIDs) 
   
   
 60
Table 13 (continued)   
Flunixin Mastitis Non-steroidal Anti-inflammatory 
drugs (NSAIDs) 
Medications  Medical conditions Class of Drug (1, 6, 28, 46) 
Lutalyse Pyometra Prostaglandin 
Estrumatae Pyometra Prostaglandin 
Oral Calcium, IV Calcium Milk fever, retained placenta Mineral Supplement 
Dextrose Metritis, ketosis Monosaccharide (energy, 
metabolism) 
Propylene glycol Retained placenta Pharmaceutical solvent 
 
BAC-STOP udder predip (Esteam Manufacturing Ltd., Calgary, Alberta) and Transcend 
udder postdip (IBA, Millbury, MA.) were used as sanitizers prior to and after milking. FC-98 
Udder Wash (IBA, Millbury, MA.) was also used a boot sanitizer. 
Discussion 
    In this longitudinal study, it was interesting to note the populations of bacteria that were 
resistant prior to and after the placement of dairy cattle. The numbers and percentage of 
bacterial and antibiotic-resistant colonies increased as cattle were placed at the facility. This 
is to be expected since many bacterial organisms (including pathogens) originate in the 
ruminant intestinal tract (25, 31, 36). However, in this study, antibiotic-resistant 
Enterococcus grew on TSA plates containing very high levels of ampicillin and 
erythromycin. The amounts of tetracycline and erythromycin incorporated into TSA (both 48 
ug/mL) were much higher than the amount deemed resistant by CLSI (> 24 ug/mL for 
ampicillin and > 12 ug/mL for erythromycin). Even at the highest concentrations, there were 
growth of antibiotic-resistant organisms, particularly after the introduction of dairy cattle-and 
more so with erythromycin when compared to ampicillin (tables 7 and 8). In addition, there 
were very high percentages of resistant populations on TSA plates containing tetracycline 
(tables 6 and 9).  One and one half times the amount of antibiotic deemed resistant by 
NARMS was incorporated into TSA (24 ug/mL) as opposed to 16 ug/mL (the recommended 
amount). Also, significant growth occurred after the placement of dairy cattle. None of the 
populations of enterococci in both A and B groups detected were resistant to tetracycline.  
    When reviewing antibiotic profiles of the populations of resistant organisms that grew on 
TSA plates at a 10-3 dilution (table 10), most had the profile of combined erythromycin and 
tetracycline resistance (n=18). Nine plates were resistant to only tetracycline (n=9) and five 
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were resistant to the three antibiotics tested (erythromycin, ampicillin and tetracycline). In 
table 11 (10-5 dilution), nine plates were resistant to ampicillin and tetracycline; eight TSA 
plates exhibited resistance to erythromycin and tetracycline; and two were resistant to the 
three antibiotic tested (erythromycin, ampicillin and tetracycline). Of the populations of 
enterococci plates that were resistant, 25 (or 66%) of the 10-3 plates were multi-drug resistant 
(table 10) and 19 (or 76%) of the 10-5 plates were multi-drug resistant (table 11). This is 
significant because multi-drug resistance is becoming more prevalent (14) and is 
compromising the treatment of disease in both humans and animals (24, 39). 
    In table 12, TNTC Enterococcosel plates are diagrammed (they were not subsequently 
tested for antibiotic resistance). In locations A and B (before dairy cattle placement), there 
were no estimated counts. However, immediately after the placement of cattle, large 
populations of enterococci began to appear. The numbers of TNTC plates were consistent 
throughout the sampling periods; C (n=8), D and G (n=7) as well as E and F (n=6). When 
reviewing specific dairy farm locations, there were 5 TNTC plates at the solids separator 
(location 10), free stall barn (location 12) and free stall walkway (location 13). There were 4 
TNTC plates at the free stall barn (location 11), holding area walkway (location 14) and the 
holding/milking area (location 15). It is interesting to note that there was only one TNTC 
plate at the special needs/hospital barn (location 16). Since the TNTC Enterococcosel plates 
could not be replicated, the actual numbers of bacterial CFUs and the antibiotic resistant 
profiles (derived from antibiotic-containing plates) are likely much higher and more 
extensive.  
    One possible limitation of this study is that slight differences in making specialized media 
may have influenced microbial counts. To account for this, a staff member who has more 
then twenty years experience making media and reagents assisted in media/reagent 
preparation. Additionally, when colonies were counted, additional staff persons verified 
colony counts. Since this study took place over a 9-month period, it would be appealing to 
continue sampling over a longer period of time. The information in this (and other) studies 
can be helpful in studying antibiotic resistance in livestock. Measures could then be 
implemented to reduce conditions leading to antibiotic resistance, and limit the spread of 
resistant infectious bacterial organisms in dairy farm environments (5). 
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Conclusion 
   There is little information on the prevalence and epidemiology of antimicrobial resistance 
in Enterococci outside the hospital setting, including on dairy farms (20). Makovec et al. 
(2003) conducted a study in which over 8900 milk samples were tested. Of the Enterococci 
identified  (n=405), erythromycin resistance increased from over time from 29% to 47% (26).  
Additionally, over 49 % of isolates were resistant to tetracycline and 38% were resistant to 
ampicillin (26). In a study of central California dairies (38), 326 environmental samples 
indentified as Streptococcus uberis (39.9%), Streptococcus dysgalactiae (42.2%) and 
Enterococcus spp. (11.1%) were tested to determine the prevalence of antibiotic 
susceptibility and resistance. Enteorcoccus spp. were the most resistant organisms tested. 
Anderson et al. (2008) compared antibiotic-resistant Enterococci in American bison and 
pastured cattle in northeastern Kansas. Cattle isolates were more resistant to erythromycin 
(12.7% versus 4% in bison) and tetracycline (42.9% versus 8% in bison) (3). Both the cattle 
and bison isolates demonstrated low resistance to ampicillin. In the African country of 
Botswana, the prevalence of antibiotic resistant enterococci in meat, beef and chicken 
products were reviewed (7). Of the 415 E. faecalis isolates, 400 were resistant to antibiotics 
(7). Ninety six percent were resistant to ampicillin and 18% were tetracycline resistant.  Ten 
percent were resistant to both ampicillin and tetracycline. Of note, a few isolates 
demonstrated MDR to vancomycin, cephalothin and teicoplanin. This is significant because 
the antibiotics used in this study represent the major groups of antibiotics used in health care 
facilities (7).  Additionally, E. faecium isolates were highly resistant to the same drugs.   
    There have been many studies of antibiotic resistance in food items such as cheeses, meats 
and fermented foods such as yogurt (45). Increased resistance of enterococci in foods is of 
interest because the ability of these organisms to infect immunocompromised hosts and cause 
serious medical conditions in humans (45). Dairy cows that develop infections caused by 
diseases such as mastitis and post-parturient disease may become chronically infected and be 
sent to slaughter prematurely (26, 41). A number of researchers advocate spending less time 
collecting antimicrobial use data citing numerous studies determining the rate of disease in 
dairy cattle (41). They also believe data could be estimated from existing datasets to develop 
reasonable estimates without the expense of additional surveys (41). However, other 
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researchers feel that it is not completely understood how widespread the frequency of 
antibiotic-resistant bacteria are in the non-nosocomial community and the lack of 
surveillance data is especially evident in important agricultural environments such as dairy 
farms (5). When completing a literature review concerning antibiotic resistance in a new 
dairy farm environment (analysis of bacteria prior to, and after placement of dairy cattle), no 
information was found at the time of this writing. To our knowledge, this is the first study of 
the establishment and proliferation of bacteria (and antibiotic resistance) before and after the 
introduction of production livestock on previously unused farm land. 
    While there may be an abundance of information regarding treatment of conditions in 
dairy cattle such as mastitis and post-parturient disease (10, 34, 41, 48) , the role that non-
human sources and reservoirs (other than hospitalized patients) may play in the spread of 
Enterococcus is controversial and poorly understood (20). Most antimicrobial studies have 
focused on bacteria such as Salmonella, enterotoxigenic Escherichia coli, and bacteria 
isolated from clinical cases (39). While there are studies that question the reported risks of 
using antibiotics in animal production (9, 42), the general consensus is that increased 
surveillance of bacteria (such as Enterococcus) and compliance with appropriate use of 
antibiotics would be beneficial to human and animal health (2, 9, 37).   Minimizing antibiotic 
resistance requires a multidisciplinary approach (14). Efforts such as creating new antibiotics 
(24) completing research that minimize bacterial infections of animals (and of humans) (3, 7, 
26), improving diagnostic skills of laboratory workers (11, 18), using antibiotics in a 
responsible (or “prudent”) fashion (37), and better farm management (41) are useful in 
addressing the issue of antibiotic resistance among humans and animals.  
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Appendix: The Iowa State University’s Dairy/Animal Science Education and Discovery 
Facility 
 
 
1) Feed Storage Area (FSA)    11) Free Stall Barn (FS11) 
2) Open Field NE (OF)        12) Free Stall Barn (FS12) 
3) Heifer Barn 9-15 months (H9)       13) Free Stall Barn Walkway (FW) 
4) Heifer Barn 2-8 months (H2)      14) Holding Area Walkway (HW) 
5) Heifer Barn 16-22 months (H16)      15) Holding Area/Milking (HM) 
6) Maternity/Calf Barn (MC 6)       16) Special Needs/Hospital Barn (SH) 
7) Maternity/Calf Barn (MC 7)     17) Parking Main Entrance (PM) 
 8) Maternity/Calf Barn (MC 8)      18) Parking/Employee/Showers (PS) 
9) Dry Cow/Transition Barn (DC)       19) Equipment Storage (ES) 
10) Solids Separator (SS)    20) Machine Storage Area (MS) 
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The establishment of Enterobacteriaceae and Salmonella london in a new dairy farm 
environment. 
   Ginger M. Shipp and James S. Dickson 
  ABSTRACT 
Salmonella spp. are important zoonotic pathogens in humans and animals (77). A 
longitudinal study was conducted on the Iowa State University’s campus (at the 
Dairy/Animal Science Education and Discovery Facility) to observe change in 
Enterobacteriaceae (specifically Salmonella) before and after the placement of dairy 
livestock. To our knowledge, this is the first study that evaluated environmental changes of 
Gram-negative organisms in a new dairy farm environment. Environmental samples were 
taken using drag swabs and immediately processed in the laboratory using phenotypic 
methods (replica plating, the BBL Crystal Identification System for enteric/nonfermenter 
organisms, and plating on specialized media/broths). Genotypic methods were also used (the 
BAX PCR system ™ and PFGE). Organisms identified as Salmonella were sent to the 
National Veterinary Services Laboratory (Ames, IA) for confirmatory serotyping. Resistance 
to antibiotics (ampicillin, nalidixic acid and tetracycline) was determined from replica plating 
of Enterobacteriaceae and Salmonella isolates using the guidelines of the National 
Antimicrobial Resistance Monitoring System (NARMS) and Clinical and Laboratory 
Standards Institute (CLSI). The microbiota of Enterobacteriaceae changed as cattle were 
introduced and as time progressed. Additionally, multi-drug resistant (MDR) isolates began 
to appear immediately after cattle were introduced (MDR isolates were rare prior to 
introduction of livestock). Variables such as temperature and humidity did not affect the 
proliferation of bacterial organisms; however this study was completed over a 9-month 
period. Seventeen Salmonella isolates were identified as S. london and three isolates as S. 
montevideo. Based on PFGE-generated dendograms, it is likely that the 17 S. london isolates 
are clonal and the 3 S. montevideo isolates are clonal. 
 
Key words: longitudinal study, dairy farm, ampicillin, nalidixic acid, tetracycline, drag 
swabs, replica plating, NARMS, CLSI, PFGE, PCR 
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     Salmonella spp. are important zoonotic pathogens in humans and animals (77). In the 
United States, human salmonellosis (caused by non-typhi Salmonella) occurs in about 1.3 
million people, causes > 500 deaths and is estimated to cost the US economy 2.3 billion to 
3.6 billion each year (10). Most cases of salmonellosis are caused by a single species, S. 
enterica which consists of over 2500 serotypes (39). Although S. enterica serotypes are 
closely related, there are important differences between them. Some serotypes are 
“generalists” that infect a wide variety of animals. For example, S. typhimurium infects hosts 
such as humans, mice and chickens (21). Other serotypes are highly host-adapted infecting 
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one or only a few species (21). For example, S. pullorum predominantly infects chickens and 
S. dublin largely infects cattle (11, 41). In one study involving serotypes infecting humans, 
only 10-100 ingested organisms were required to cause illness (6).  
   Although the majority of human Salmonella infections result in asymptomatic or self-
limiting diarrheal illness, life-threatening bacteremias and other infections do occur-
particularly in immunocompromised hosts, neonates and the elderly (82). Outbreaks of non-
typhoidal Salmonella infections and sporadic illness have been associated with foods of 
animal origins, fruits and vegetables contaminated with manure, and contact with animals, 
including reptiles (77). For example, salmonellosis on dairy farms can be costly to dairy 
producers because of treatment costs, increased culling rates, decreased weight gain, and 
decreased milk production (32).  
    Bacteria are an important part of the soil microbiota because of their abundance, their 
species diversity, and the multiplicity of their metabolic activities (56). Traditional microbial 
culture is considered the established method for the examination of environmental 
microorganisms (33). In microbial culture, samples are collected, transported to the 
laboratory, and dispersed on various media having the required nutrients and physiochemical 
conditions for growth (33, 66). After a suitable period of incubation, colonies are subcultured 
and identified according to variables such as colony and cellular morphology, Gram-stain 
pattern and biochemical characteristics (33). Culture methods can detect very small number 
of cells, and approaches such as formulating the medium to target the growth of specific 
bacteria (while inhibiting others) can be implemented for more sophisticated and specific 
measurements  (13). Cultural detection also allows for quantification of microorganisms with 
considerable precision (81). However, culturing can be time-consuming and take up to 7 days 
to complete (65). In addition, culturing can be inefficient for epidemiological studies 
involving the low prevalence of bacterial organisms-due to large number of samples that are 
typically required (65). Bacteria can also be uncultivable, and viable cells that lose the ability 
to form colonies may not be detected (13, 36). Plate counts assume that during the process of 
plating, individual colonies are separated and will form discreet colonies; if cells are 
aggregated, underestimation may occur (13). Despite the disadvantages, the ability of 
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microbiologists to cultivate bacteria is still considered extremely important to obtain a 
thorough understanding and evaluation of microbial communities (23, 56). 
    During the last 25 years, molecular techniques have increased in prominence, allowing 
individual bacterial species to be identified and sometimes quantified from environmental 
samples (13, 23).  Rapid enumeration of bacteria is completed using a variety of approaches. 
Polymerase Chain Reaction (PCR) technology is used to decrease the time and increase the 
sensitivity of detection of bacteria in food, environmental, and clinical samples (65). During 
PCR, large quantities of a specific gene fragment can be synthesized during repeated cycles 
of denaturation, primer annealing and DNA polymerase-catalyzed elongation (23). PCR is a 
specific and sensitive technique used to detect nucleic acids; however the presence of 
inhibitory compounds may affect the PCR reaction and give a false positive result (16). 
Suboptimal reaction conditions (inappropriate primers, improper temperature conditions, 
incorrect Mg2+ concentration) may also influence the outcome of PCR (81).  
    Another DNA-based technology that is used to identify bacterial species and their 
relatedness is Pulsed-Field Gel Electrophoresis (PFGE). PFGE “fingerprints” reflects the 
structural organization of bacterial chromosome (55). In PFGE, suspended bacterial cells are 
embedded in an agarose “plug” and chromosomal DNA is digested with restriction 
enzyme(s) (which cuts the chromosome in fragments of varying size). The digested plugs are 
then placed in larger agarose gel and positioned in an electrophoresis chamber. Electrical 
pulses are applied to the gel resulting in size-dependent movement of DNA fragments 
(smaller fragments migrate faster through agarose than larger fragments). Contour-clamped 
Homogeneous Electrical Field (CHEF) electrophoresis uses a complex electrophoresis 
chamber with multiple electrodes to achieve a uniform electrophoretic field resulting in better 
resolution of DNA fragments (4). PFGE is the current “gold standard” for highly 
discriminatory subtyping of most bacterial pathogens (27, 66) including Salmonella spp. The 
disadvantages of PFGE are complex and time-consuming DNA preparation and 
electrophoresis (85), costly reagents and the costs of electrophoresis equipment (46). 
Furthermore, certain organisms such as Clostridium difficile may not be typeable by PFGE 
because their DNA can not be extracted intact (71). 
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    The Iowa State University’s Dairy/Animal Science Education and Discovery Facility 
(henceforth referred to as the “ISU Dairy Farm”) is located on an 887-acre site three miles 
south of ISU’s central campus. The farm houses 450 milking cows-plus a similar number of 
heifers, dry cows, and calves. A complex of buildings were constructed on 27 acres of land 
including a free-stall barn, special needs/hospital barn, maternity barn, and a calf research 
barn for nutritional and husbandry studies. The land the ISU Dairy Farm now occupies was 
donated to the university by a donor. The farm had been recreational and no production 
livestock had ever been introduced.  Dairy cattle were placed on the farm beginning on 26 
November 2007 (a map of the dairy farm is located in the appendix of this paper). Most of 
the animals were moved from the former ISU teaching farm located about 20 miles north of 
campus (in Ankeny IA). Additionally, 50 cows were introduced to the new ISU Dairy Farm 
from a dairy center in Calmar, IA.  
    A longitudinal study was conducted to observe the change in environmental 
microorganisms before and after the placement of dairy livestock (paying particular attention 
to Enterobacteriaceae and Salmonella spp.) Phenotypic and genotypic methods (such as 
biochemical requirements of organisms and PFGE profiles, respectively) were utilized to 
identify and classify organisms.  Research described in this paper was completed during 
seven sampling periods (table 1). 
 Materials and methods 
    One sterile 3 cm x 3 cm drag swab moistened with 10 mL skim milk (Solar Biologics, 
Ogdensburg, NY) was used per sample. Briefly, a drag swab was pulled through the farm 
environment (table 2 and page 92) for 60 seconds. Each sample was placed in a cooler kept at 
4º C. 
Table 1. ISU Dairy Farm sampling dates 
Prior to introducing dairy cattle After the introduction of dairy cattle 
    20 October 2007 (A)     27 January 2008 (C) 
    13 November 2007 (B)     29 February 2008 (D) 
     12 March 2008 (E) 
     23 April 2008 (F) 
     28 May 2008 (G) 
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Table 2. ISU Dairy Farm Sampling Locations      
    1) Feed Storage Area (FSA) 11) Free Stall Barn (FS 11) 
    2) Open Field NE (OF) 12) Free Stall Barn (FS 12) 
    3) Heifer Barn 9-15 months (H9) 13) Free Stall Barn Walkway (FW) 
    4) Heifer Barn 2-8 months (H2) 14) Holding Area Walkway (HW) 
    5) Heifer Barn 16-22 months (H16) 15) Holding Area Milking (HM) 
    6) Maternity/Calf Barn (MC 6) 16) Special Needs/Hospital Barn (SH) 
    7) Maternity/Calf Barn (MC 7) 17) Parking Main Entrance (PM) 
    8) Maternity/Calf Barn (MC 8) 18) Parking/Employee/Showers (PS) 
    9) Dry Cow/Transition Barn (DC) 19) Equipment Storage (ES) 
    10)  Solids Separator (SS) 20) Machine Storage Area (MS) 
 
After collection, samples were taken to the laboratory and immediately processed. Each drag 
swab was aseptically added to a sterile Whirl Pack 24 oz/720 mL filtered homogenizer bag 
(Nasco, Fork Atkinson, WI) containing 10 mL of buffered peptone water (BPW; Difco, 
Becton Dickinson Company, Sparks, MD) to add moisture for easier pipetting. The sample 
was homogenized for 45 seconds at 250 rpm. One ml of sample was added to a tube 
containing 9 mL BPW creating a dilutent concentration of 10 -1. The samples were then 
serially diluted to a 10-4 concentration. A quantity of 0.1 ml 10-4 diluent was plated on XLT-4 
agar and incubated for 48 hours at 37 ºC. (results were recorded as 10-5). Each plate was later 
screened for presence or absence of black colonies, characteristic of Salmonella spp a and 
populations of typical salmonella colonies were enumerated after incubation. The BBL 
Crystal Identification Systems Enteric/Nonfermenter ID kit (Sparks, MD) was used to further 
identify colonies to the genus and species level. 
    Resistance to antibiotics was also investigated over time via replica plating. Replica 
plating has been used widely since its invention by Lederberg and Lederberg (48). It involves 
identifying and counting bacterial colonies on a master plate then later “replicate” (or stamp) 
the colonies from the master plate onto several different antibiotic-containing plates (51). 
This method makes it possible to determine the frequency of 
resistant and susceptible strains in each sample (51).  In this study, colonies from XLT-4 
aXLT-4 is a selective culture medium and is used for identification of salmonellae from food and environmental 
samples. XLT-4 utilizes the detergent tergitol to obtain a nearly complete inhibition of Proteus spp.. 
Additionally, sodium thiosulfate from H2S production reacts with ammonium sulfate (incorporated in the agar) 
to form black colonies, characteristic of salmonellae (19). Salmonella is differentiated on XLT-4 agar from 
other organisms such as Escherichia coli (growth of yellow colonies) and Shigella species (growth of red 
colonies).  (14, 19) 
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media were replica plated (using a replica plating cylinder covered with velvet) onto Tryptic 
Soy Agar (Difco, Becton Dickinson Company, Sparks, MD) containing ampicillin (48 
ug/mL; Sigma, St. Louis, MO), nalidixic acid (48 ug/mL; Sigma, St. Louis, MO) and 
tetracycline (24 ug/mL; MP Biomedicals, Solon OH); these quantities were at least 1.5 times 
the concentrations recommended by the National Antimicrobial Resistance Monitoring 
System (NARMS)b. Replica plating has been shown to be effective with large numbers of 
environmental samples (51), however it requires a high level of training and expertise (29). 
Additionally, antibiotic-containing plates have a very short shelf-life and require frequent 
preparation which often takes place in longitudinal studies or in clinical laboratory settings 
(29).  Therefore, all antibiotic-containing replica plates were prepared using the guidelines of 
the Clinical and Laboratory Standards Institute (CLSI) and refrigerated 1-2 weeks before 
sampling was carried out. 
  The BAX PCR system™ (Qualicon Inc., Wilmington, DE, USA) was used to screen for 
Salmonella. The BAX system uses real-time PCR to detect and confirm the presence of 
target organisms (such as Salmonella) within 24 hours (57). After a standard enrichment, 
cells were lysed to release DNA and placed in the BAX system for detection (12). BAX PCR 
is sensitive, accurate and rapid (results can be known in as little as 13-24  
hours), however, prolonged enrichment is required to detect lower levels of bacterial 
contamination (42). Additionally, false positive and false negative results have been  
reported (31, 74).  In this study, a 5 ul aliquot of 10-1 BPW diluent (taken from specified 
locations on the dairy farm) was enriched and later added to 200 ul of lysis buffer. After 
incubation at 37 ºC for 20 minutes and 95ºC for 10 minutes, the lysate was cooled in a 
cooling block. Fifty microliters (uL) of the lysate was combined with a tablet containing PCR 
reactants (provided in the screening kit) and subjected to real-time PCR in a BAX System Q7 
Thermocycler (Applied Biosystems, Wilmington DE, USA) using the thermocycling  
 
bNARMS is a collaborative effort between the Food and Drug Administration (FDA), the United States 
Department of Agriculture (USDA), and the Centers for Disease Control and Prevention (CDC) (58). NARMS 
monitors changes in antimicrobial susceptibility of enteric bacteria from human and animal  
sources (58). 
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program recommended by the manufacturer. Positive and negative controls were used 
(Salmonella spp., Enterococcus faecalis and Listeria monocytogenes) during PCR and each 
10-1 diluent was processed for PCR (for a total of  
140 PCR reactions completed). Once BAX samples were identified as Salmonella positive, 
they were later cultured with additional specialized media to identify salmonellae for PFGE 
and serotyping (table 3). Diluted samples were also plated on specialized media (in addition  
 
Table 3. Additional media used for identification of Salmonella spp.  
Bismuth Sulfite agar (Acumeida, Baltimore, MD.)  
Eosin methylene blue agar (Difco, Becton Dickinson, Sparks, MD) 
Hecton-Enteric agar (Remel, Lenexa, KS.) 
MacConkey agar (Difco, Becton Dickinson, Sparks, MD) 
Salmonella-Shigella agar (Difco, Becton Dickinson, Sparks, MD) 
Tetrathionate Broth (Difco, Becton Dickinson, Sparks, MD) 
Rappaport-Vassiliadis Broth (Difco, Becton Dickinson, Sparks, MD) 
Terrific Broth (Difco, Becton Dickinson, Sparks, MD) 
 
to XLT-4) because there may have been overgrowth of Salmonella by Enterobacteriaceae 
such as E. coli and Shigella. Data were analyzed by EpiInfo (version 3.5), a public domain 
software program created by the CDC’s PulseNet Program (Atlanta GA) at 95% confidence 
limits. 
PFGE 
  Chromosomal DNA was prepared following the PFGE protocol developed by the CDC 
PulseNet program (60) with some modifications; agarose plugs were incubated overnight at 
37º C using 10 uL of Xba I (5000 U, 10 U/mL, Roche Diagnostics, Mannheim, Germany). 
PFGE was carried out with a CHEF III Mapper System (Bio-Rad Laboratories, Hercules, 
CA). The running conditions were as follows; initial switch time, 2.2 s, final switch time, 
63.8 s, at 6 volts. The induced angle was 120º and run time, 19 h. Fragments were estimated 
by comparison with a lambda ladder (Bio-Rad Laboratories, Hercules, CA) as a molecular 
marker. The gels were stained with ethidium bromide and visualized under a UV light using 
a Gel Doc 2000 (Bio-Rad Laboratories, Hercules, CA.).  PFGE patterns were analyzed by the 
BioNumerics software program, version 2.0 (Applied Maths, Kortrijk, Belgium). 
Dendograms were generated using the Dice coefficient for similarity and unweighed pair 
groups method with arithmetic mean (UPGMA) clustering. 
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Results 
Environmental microflora results 
There were a variety of microbiota detected prior to and after the placement of dairy cattle 
(table 4).  The family Enterobacteriaceae represent a large and diverse taxonomic 
 
Table 4: Environmental Microbiota of the ISU Dairy Farm 
                         
 
  Before Introduction of Cattle  
    A group  Morganella morganii, Enterobacter cloacae  
    B group  Citrobacter freundii, Enterobacter 
cancerogenus, E. cloacae, Klebsiella oxytica, 
Stenotropomonas mattophilia 
After Introduction of Cattle  
    C group  Acinetobacter iwatii, Escherichia coli 
    D group  E. coli, Pantoea agglomerans, Cedeca lapagei, 
Proteus mirabilis, Klebsiella pneumoniae 
    E group   Citrobacter amalonaticus, E. cancerogenus, 
    F group  Pseudomonas putida, C. freundii, E. coli, 
Hafnia alvei 
   G Group  C. freundii, E. coli, Hafnia alvei 
 
group (34). Some genera are very uncommon and cause more plant disease than human 
illness (Pantoea) while others are common and important in human hospital-acquired 
infections (Proteus). There are genera that rarely cause human disease but can cause illness 
and death in the immunocompromised (Morganella, Citrobacter and Hafnia). Conversely, 
Klebsiella is a cause of mastitis in cattle (35) and has been implicated in outbreaks (28). In 
humans, Klebsiella is a frequent cause of illnesses such as urinary tract infections and 
respiratory disease; Klebsiella has also been identified in outbreaks at intensive care facilities 
(34). A recent discovered genus (Cedeca, named in honor of the CDC) is increasingly 
implicated in human wound infections. All Enterobacteriaceae are characterized by their 
ubiquitous nature and the ability to form niches where they can grow and proliferate (34). 
Salmonella Serotypes  
 All environmental samples were enriched to identify salmonellae using specialized agar 
media (table 3). Colonies phenotypically identified as Salmonella were sent to the National 
Veterinary Services Lab (NVSL) for confirmatory serotyping.  Twenty were identified as 
 76
Salmonella spp. (table 5); of those, seventeen were serotyped as S. london and remaining 
three were identified as S. montevideo. 
Table 5 Serotyping results (group and farm location) 
Salmonella london (n=17) Salmonella montevideo (n=3) 
    D11 (FS11), D13 (FW), E10 (SS), E11 
   (FS11), E12 (FS12), E13 (FW), E14 
   (HW), F6 (MC6), F10 (SS), F11 (FS11), 
    F12 (FS12), F13 (FW), F14 (HW), F15 
   (HM), F16 (SH), G10 (SS), G13 (FW) 
    D10 (SS), D14 (HW), D15 (HM) 
 
All salmonellae were found after dairy cattle placement.  S. montevideo has been identified as 
one of the most common Salmonella isolates found on dairy farms (76, 79) and has been 
implicated in outbreaks caused by cheese made from raw milk (17)  and bean sprouts (78). 
Outbreaks have also take place among sheep and wild birds (59). In a study of antibiotic 
susceptibility of Salmonella and U.S. dairy farms by the USDA Animal and Plant Health 
Inspection Service (APHIS) , S. montevideo isolates were sensitive to streptomycin and 
ampicillin (34%  and 9%, respectively), but resistant to tetracycline (76). However, little is 
known about the rare (but emerging) serotype S. london.  Most human cases have been 
reported in Korea and are typically related to the consumption of food products including 
powdered milk and other dairy products (37, 53).  In early reports regarding the antimicrobial 
susceptibility of S. london, all isolates tested were sensitive to drugs such as chloramphenicol 
(63). However, S. london is beginning to spread world-wide and has been implicated in 
products other than dairy-related items (7, 62). Pet chews, pig meat, meat products, and 
environmental wastewater have been found to harbor S. london (7, 83, 84).   In addition, 
there is much variation in the antibiotic resistance of S. london isolates.  In a 2006 study of 
wastewater in Spain, S. london isolates were sensitive to all antibiotics tested (including 
ampicillin, nalidixic acid and tetracycline) (25). In a New Zealand study, Wong et al. (2009) 
found that three isolates of S. london discovered on pet treats were resistant to ampicillin, but 
sensitive to a panel of antibiotics (including nalidixic acid and tetracycline) (84). In a 2009 
U.S. study on the prevalence of salmonellae in ground meats, S. london was found to be 
sensitive to tetracycline but resistant to antibiotics such as ampicillin and nalidixic acid (7). 
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  In this study, the numbers of Salmonella colonies identified on 10-5 XLT-4 plates (plated 
directly from the farm environment to XLT-4 agar) were extremely low. Of all the XLT-4 
plates inoculated with environmental diluents (20 10-5 plates per sampling date, 7 sampling 
dates, for a total of 140 plates), only three XLT-4 plates were found depicting colonies 
phenotypically consistent with Salmonella; F10 (SS; solids separator), F13 (FW; free stall 
walkway), and F16 (SH; special needs/hospital barn) (tables 2 and 5). All phenotypiclly-
appearing Salmonella colonies were identified in the F group (after dairy cattle were 
introduced). Black colonies were marked on the XLT-4 plates while replica plating and 
antibiotic resistance profiles were determined from those colonies (table 6). The isolates 
studied were resistant to ampicillin and tetracycline, but susceptible to nalidixic acid. 
 
Table 6. Specific antibiotic resistance of XLT-4 identified salmonellae from 10-5 
dilutions* 
 
*Farm 
Location 
XLT (5) 
(black) 
Log10 
total 
numbers 
 Amp 
48 
Nal 
48 
 Tet 
24 
Per 
Amp 
48 
Per 
Nal 
48 
Per 
Tet 24 
ARP 
F10 (SS) 3    0.48 1 0 1 33 0 33 AT 
F13 (FW) 6    0.78 1 0 6 17 0 100 AT 
F16 (SH) 7    0.85 3 0 9 43 0 129 AT 
* Number XLT (5) (number of colonies growing on XLT-4 10-5 plates), Amp=ampicillin, Nal=nalidixic acid, 
Tet=tetracycline, Per= percent, ARP= antibiotic resistance profile. 
 
   Most colonies that grew on XLT-4 plates were phenotypically consistent with 
Enterobacteriaceae such as Escherichia coli (production of yellow colonies). Other Gram-
negative bacteria that will grow on XLT-4 plates includes Citrobacter, Proteus, and 
Enterobacter (14). When XLT-4 plates were replica plated on TSA agar containing a 
predetermined amount of antibiotic, the numbers, percentages and antibiotic resistance 
profile of each location was recorded (table 5). When analyzing isolates using the CDC’s 
EpiInfo program, there were a total of 2061 colonies that grew on XLT-4 plates during the 
course of this experiment. Most colonies (667) grew in the E group (sampling date 12 March 
2008); the fewest number of colonies (9) were detected during the first sampling period (A, 
30 November 2007).  Of those, 667 were resistant to at least one antibiotic (32% of colonies). 
When reviewing antibiotics and the numbers of colonies resistant during all sampling 
periods, there were 791 isolates (38%) resistant to ampicillin, 27 isolates (or 1.3%) resistant 
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to nalidixic acid, and 170 (8%) resistant to tetracycline. Additionally, there was a more 
detailed review of antibiotic resistance by groups (A-G) and location (1-20) by both the 
numbers of colonies and resistance (table 7). BAX PCR™ results (indicative of Salmonella 
spp.) are also listed by group and location. Prior to the introduction of cattle, ampicillin 
resistance was detected in locations A5 and A9 (heifer barn, 16-22 months and the dry 
cow/transition barn, respectively). Antibiotic resistance was not detected in sampling period 
B (13 November 2007). After the animals were introduced (sampling periods C-H), there 
was an increase in the number of isolates resistant to one antibiotic (ampicillin or 
tetracycline) as well as MDR.  Interestingly, resistance is spread throughout the dairy farm 
and not limited to certain expected locations (such as the free stall barn and special 
needs/hospital barn). Resistance to ampicillin only (n=9) occurs in many of the sampling 
periods-with the exceptions of B and F (27 January 2008 and 23 April, 2008). Both 
tetracycline and nalidixic acid/tetracycline resistance were detected after the placement of 
cattle (table 7). A combination of ampicillin and nalidixic acid resistance (n=4) were found in 
locations D and F; in D3, the heifer barn (H9); in F1, the free stall area (FSA); in F5, the 
heifer barn-16-22 months (H16); and in F17, the main parking lot entrance (PM). No 
ampicillin/tetracycline resistance was detected before the introduction of cows, however, 
after introduction, this antibiotic resistance profile (n=13) was detected in the remaining 
sampling periods (C-G) all being indoor locations such as the maternity and calf barns (D8 or 
MC8);  free stall barns  (E11 or FS11)  and special needs/hospital barns (SH). Likewise, the 
ampicillin/nalidixic/tetracycline profile were identified after the  
 
Table 7. XLT-4 Colony Growth, Antibiotic Resistance and Pattern, BAX * 
Farm 
Location NumberXLT4 
 Amp 
48 Nal 48 
 Tet 
24 
Per 
Amp 48 
Per Nal 
48 
Per Tet 
24 ABP 
BAX 
PCR 
A 5 (H16) 2 2 0 0 100 0 0 A (-) 
A 9 (DC) 5 4 0 0 80 0 0 A (-) 
A 12 
(FS12) 2 2 0 0 100 0 0 A 
(+) 
C 3 (H9) 1 1 0 0 100 0 0 A (-) 
C 14 
(HW) 21 8 0 0 38 0 0 A 
(+) 
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Table 7. (continued) 
Farm 
Location NumberXLT4 
 Amp 
48 Nal 48 
 Tet 
24 
Per 
Amp 48 
Per Nal 
48 
Per Tet 
24 ABP 
BAX 
PCR 
D 12 
(FS12) 110 80 0 0 73 0 0 A 
(+) 
E 8 (MC8) 1 3 0 0 300 0 0 A (+) 
G 17 (PM) 35 35 0 0 100 0 0 A (+) 
G 19 (ES) 1 5 0 0 500 0 0 A (+) 
          
C 9 (DC) 2 0 0 1 0 0 50 T (-) 
G 16 (SH) 2 0 0 2 0 0 100 T (-) 
          
D 11 
(FS11) 14 0 1 8 0 7 57 NT 
(+) 
 
 
        
 
D 3 (H9) 3 4 1 0 133 33 0 AN (-) 
F1 (FSA) 22 25 2 0 113 9 0 AN (-) 
F 5 (H16) 13 18 3 0 138 23 0 AN (-) 
F 17 (PM) 5 7 1 0 140 20 0 AN (-) 
          
C 16 (SH) 10 13 0 9 130 0 90 AT (+) 
D 8 (MC8) 155 96 0 57 62 0 37 AT (-) 
D 13 (FW) 110 13 0 49 12 0 45 AT (+) 
D 15 
(HM) 81 12 0 44 15 0 54 AT 
(+) 
E 5 (H16) 7 2 0 4 29 0 57 AT (-) 
E 11 
(FS11) 33 5 0 21 15 0 64 AT 
(+) 
E 16 (SH) 248 7 0 72 3 0 29 AT (+) 
F 6 (MC6) 2 2 0 1 100 0 50 AT (-) 
F 7 (MC7) 53 40 0 52 75 0 98 AT (-) 
G 6 (MC 
6) 4 9 0 7 225 0 175 AT 
(+) 
G11 
(FS11) 60 6 0 9 10 0 15 AT 
(+) 
G 12 
(FS12) 35 3 0 27 9 0 77 AT 
(+) 
G 16 (SH) 3 1 0 1 33 0 33 AT (-) 
          
C 8 (MC8) 20 17 1 25 85 5 125 ANT (-) 
D 6 (MC6) 49 39 1 41 80 2 84 ANT (-) 
E 1 (FSA) 4 19 7 6 225 175 150 ANT (-) 
E 13 (FW) 152 6 6 67 4 4 152 ANT (+) 
F 8 (MC8) 24 49 17 7 204 71 29 ANT (-) 
F 16 (SH) 9 4 2 15 44 22 167 ANT (-) 
G 2 (OF) 27 39 11 7 144 41 26 ANT (-) 
G 4 (H2) 260 88 1 48 34 1 18 ANT (-) 
G 5 (H16) 32 27 1 3 85 3 9 ANT (-) 
G 8 (MC8) 64 77 13 9 120 20 14 ANT (-) 
G 9 (DC) 12 10 1 3 83 8 25 ANT (-) 
Amp=ampicillin, Nal=nalidixic acid, Tet=tetracycline, Per= percent, ARP= antibiotic resistance profile. 
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introduction of cattle and is spread throughout the farm environment-one (G2) being detected 
in an open field (OF).  Overall, the percentages of nalidixic acid (only) resistant colonies 
were small (when compared to ampicillin and tetracycline). Also, it was noted that the 
numbers of XLT-4 colonies (and antibiotic-resistant colonies) would change as sampling 
progressed. Often the numbers would drop, then percentages would rise-and later decrease. 
When examining tetracycline resistance only, the few colonies that grew exhibited high 
antibiotic resistance (50 and 100%, respectively). There were similar results in both 
ampicillin/nalidixic acid-resistant colonies (increase then decrease) as with the 
ampicillin/nalidixic/tetracycline-resistant colonies. Overall, there were no steady increases 
(as would be expected) as Enterobacteriaceae became more established.   
    When examining the BAX PCR™ results, there was a relationship between the number of 
detected “Salmonella positive” isolates (n=42) and the dairy farm location;  
 
Figure 1: ISU Dairy Farm locations and BAX PCR results 
  
 
Most of the BAX positive results were in locations 12, the free stall barn (FS n=6); locations 
11 and 13, the free stall barn, and the free stall barn walkway (FS11 and FW n=5); and 
locations 10, 14 and 15, the solids separator, holding area walkway, and the holding area 
milking (SS, HW and HM respectively, n=4). The special needs/hospital barn (SH16) 
reported only 2 BAX Salmonella-positive results. Location 2, open field north east (OF), 
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location 5, heifer barn 16-22 months (H16) and location 9, the dry cow/transition barn (DC) 
reported negative BAX PCR results during the study.  
PFGE Results 
When reviewing the PFGE macrorestriction patterns of S. montevideo using the criteria of 
Tenover et al. (70), there was a one-fragment difference between cluster 1 (F10, F15) and 
cluster 2 (F14) which is consistent the gain of a DNA restriction site. When examining the 
PFGE macrorestriction patterns of S. london, again using the criteria of Tenover, et al. (also 
see figure  2, lanes 6-9 and 11-13), the patterns appear to be identical, indicating that isolates 
are indistinguishable from one another (69).  When examining Bionumerics-generated 
dendograms of the PFGE patterns of S. montevideo (partial data, figure 2 lanes 3 and 4), 
there were two clusters. The members of cluster 1 included D10, the solids separator (SS) 
and D15, the holding/milking area (HM); the only member of cluster 2 was D14 the holding 
area walkway (HW). The PFGE profiles of S. 1ondon (figure 3) resulted in two distinct 
clusters; cluster 1 (F16, G10, G13, F12, F14, F15, F13, F11 and F10) and cluster 2 (D11, 
E11, E10, D13, E13, E12, F6 AND E14) both with at least 85% similarity (also see figure 3 
for farm locations).  All Salmonella isolates were discovered after cattle were introduced on 
the dairy farm which suggests that the source of the isolates were likely cattle (43, 68) 
although there can be other  
Figure 2. Example of a PFGE gel with S. montevideo and S. london isolates (lanes on next 
page) 
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Figure 2. (continued) 
Lanes 1 and 15, Lambda ladder standard; Lanes 3 and 4, D14 and D15 (S. montevideo); Lanes 6-9 and 11-13, S. 
london D11, D13, E10, E11, E12, E13, and E14 respectively). 
 
 
sources of the organism (see discussion section). In addition, in PFGE analysis, a 1 or 2 band 
difference may not indicate a difference in strains. Researchers have suggested that isolates 
with such minor profile differences are clonally related (defined as isolates recovered from 
different sources, locations, and at different times demonstrating many identical phenotypic 
and genotypic traits) (22, 72). When examining the information within both clusters, most of 
cluster 1 isolates (7/9 or 78%) were collected on 23 April 2008 within the large complex that 
housed adult animals (free stall barn, special needs/hospital barn, holding areas). The 
majority of cluster 2 isolates (5/8 or 63%) were collected on 12 March 2008, again within the 
complex that housed adult animals. 
 
Figure 3. Dendrogram of relatedness of DNA profiles of PFGE strains (S. london) in study 
 
Medications and Sanitizers: 
Medications were used to treat conditions such as mastitis, bovine respiratory disease and 
wound infections (tables 8 and 9). The medications were prescribed by an ISU faculty 
veterinarian who disclosed uses and dosages given.  Sick cattle were treated individually. In 
addition, a detailed protocol for treatment was strictly followed by the ISU Dairy Farm staff. 
 Percent  Similarity 
100806040
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S. London
S. London 
S. London 
S. London 
S. London 
S. London 
S. London 
S. London 
S. London 
S. London 
S. London 
S. London 
S. London 
S. London 
S. London 
S. London 
S. London 
F16 SH
G10 SS
G13 FW
F12 FS 12
F 14 HW
F15 HM
F13 FW
F11 FS11
F10 SS
D11 HW
E11 FS11
E10 SS
D13 FW
E 13 FW
E 12 FS 12
F6 MC 6
E14 HW
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BAC-STOP udder predip (Esteam Manufacturing Ltd., Calgary, Alberta) and Transcend 
udder postdip (IBA, Millbury, MA.) were used as sanitizers prior to and after milking. FC-98 
Udder Wash (IBA, Millbury, MA.) was also used a boot sanitizer 
Discussion:  
    When evaluating Enterobacteriaceae isolated before and after dairy cattle  placement, 
there was a change from the detection of organisms that rarely cause disease in humans and 
animals (Morganella and Citrobacter freundii) (40, 49) to organisms frequently 
causing illness (E. coli and Klebsiella) (38, 67). It is likely that pathogenic organisms 
(including salmonellae) were introduced by cattle (43, 61, 68, 75). There is also the 
possibility that pathogenic bacterial organisms could have been introduced by other 
 
Table 8: List of antibiotics used on the ISU Dairy Farm (name, class, and mode of action) 
Antibiotic(s) Class  Treatment(s) Mode of action (1, 8, 
44, 80) 
Liquamycin  Tetracycline Pneumonia 
(shipping fever), 
scours, wound 
infections 
Inhibits protein 
synthesis 
Antibiotic(s) Class  Treatment(s) Mode of action (1, 8, 
44, 80) 
Draxxin, Tylan Marcolide Draxxin-Bovine 
Respiratory Disease 
Tylan-shipping  
fever, pneumonia, 
foot rot, calf 
diphtheria 
Inhibits protein 
synthesis 
Nuflor Chloramphenicol Bovine Respiratory 
Disease 
Inhibits protein 
synthesis 
Pirsue Lincosamide Clinical and 
subclinical mastitis 
Inhibits protein 
synthesis 
Excenel, Spectramast LC, 
Spectramast DC,  Naxcel 
Cephalosporin Clinical and 
subclinical mastitis 
Inhibits cell wall 
synthesis 
Polyflex Penicillin Broad spectrum 
antibiotic, shipping 
fever, pneumonia 
Inhibits cell wall 
synthesis 
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Table 9: Additional medications used on the ISU Dairy Farm 
Medication Purpose (1, 8, 44, 80) 
Banamine Non-Steroidal Anti-Inflammatory Drug 
Sterile Saline, Hypertonic Saline Solution Intravenous therapy  
 
animals and insects attracted to the facility after dairy cattle placement (competing with cattle 
for shelter and food, for example) (18, 50) or by materials brought into the dairy farm such as 
hay, bedding and mattresses (47). 
    BAX PCR™ was much more sensitive at detecting salmonellae in environmental samples 
(table 7 and figure 1) than sampling with XLT-4 (table 6) or using specialized media to 
recover Salmonella in isolates (table 3). In a Swedish study (24) comparing BAX PCR ™ to 
other methods of detection such as modified semisolid Rappaaport-Vassiliadis agar (MSRV) 
and the selective Enzyme-Linked Immunoabsorbent Assay (ELISA), MSRV performed 
slightly better than BAX (93% accuracy and 88% sensitive for BAX versus 99% accuracy 
and 98% sensitivity for MSRV). The selective ELISA was only 78% accurate and 63% 
sensitive. Swedish researchers used fecal samples “spiked” with Salmonella, artificially 
contaminated poultry swine, and other fecal samples. Other studies have also attested to the 
high accuracy and sensitivity of the BAX method (5, 73, 74). 
    The percentage of antibiotic resistance of Enterobacteriaceae (table 7) did not depend on 
factors such as temperature and humidity also referred to “seasonality” in some literature 
(30); however, this study was done over a 9-month period. Additionally, the lack of 
seasonality has been supported by studies in the US (54) and internationally (64). 
Conversely, there are studies that depicted the seasonality of Salmonella (20, 30). In the ISU 
Dairy Farm study, antibiotic-resistant colonies were discovered throughout the sampling 
periods. However, MDR colonies appeared after cattle were introduced (e.g. 
ampicillin/nalidixic acid resistance first appeared at the dry cow/transition barn (D9); 
ampicillin/tetracycline resistance initially appeared at the special needs/hospital barn (C16); 
and ampicillin/nalidixic acid/tetracycline resistance initially appeared in the maternity/calf 
barn (C8). Of note, the percentages of antibiotic resistance varied during sampling periods as 
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in other studies (54). There were also intermittent levels of Salmonella (repeated decreases 
and increases in bacterial levels) during the ISU Dairy farm study, again similar to results in 
other studies (52). 
    Although animals can be infected clinically or subclincally, Salmonella often persists in 
the subclinical form, making detection of infected animals difficult (52). Carrier animals may 
also play an important role in the spread of infections in herds and consequently serve as 
sources of food contamination and human infection (86). Emergence of MDR Salmonella 
reduces therapeutic options in cases of infection in humans and animals. MDR resistance is 
an increasingly important issue world-wide; examples include studies in the US (2) China 
(15) and Brazil (26).  
 Conclusion: 
  From this experiments (and others cited in this article), there is value in continued 
monitoring of changes in bacteria in farming environments-particularly changes in 
antimicrobial susceptibility and resistance. To our knowledge, this is the first study that 
evaluated the change of Enterobacteriaceae (and specifically Salmonella) before and after 
the placement of production animals (dairy cattle). This work has demonstrated that 
organisms of medical importance such as Salmonella have the ability to quickly establish and 
proliferate on dairy facilities. It would be interesting to continue longitudinal studies to 
survey ongoing changes in environmental microbiota. In addition, additional antibiotics 
could be used to obtain more extensive antibiotic-resistance profiles. However, more 
extensive replica plating experiments and costs would likely be prohibitive.  
     Surveillance programs are helpful in documenting (and preventing) the spread of 
pathogenic bacteria. However, there is concern that passive laboratory-based surveillance is 
likely to underreport the true incidence of diseases such as salmonellosis in livestock (3, 86). 
Surveillance activities can be combined with additional approaches to decrease the effects of 
antibiotic resistance as reported by researchers such as McAllister et al. (2001) and Oliver et 
al. (2009). They include 1) not using antibiotics to compensate for poor nutrition, poor 
hygiene, or the lack of immunization; 2) using antibiotics in consultation with a veterinarian; 
3) minimizing as much as possible the use of antibiotics considered important for treating 
human diseases; 4) using probiotics to compete with potentially pathogenic bacteria (a 
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probiotic is defined as a feed product containing viable, defined organisms which alters the 
microbiota in a host and exerts beneficial health effects) (45, 50). Additionally research such 
as those reviewing  the association between management type (organic versus conventional 
farms) is now taking place (3). The US has the safest food supply in the world, however 
foodborne pathogens can be a significant threat to human health (9). Therefore it is important 
to study the epidemiology of antibiotic resistance within both animal and human populations.  
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Appendix: The Iowa State University’s Dairy/Animal Science Education and Discovery 
Facility 
 
 
1) Feed Storage Area (FSA)    11) Free Stall Barn (FS11) 
2) Open Field NE (OF)        12) Free Stall Barn (FS12) 
3) Heifer Barn 9-15 months (H9)       13) Free Stall Barn Walkway (FW) 
4) Heifer Barn 2-8 months (H2)      14) Holding Area Walkway (HW) 
5) Heifer Barn 16-22 months (H16)      15) Holding Area/Milking (HM) 
6) Maternity/Calf Barn (MC 6)       16) Special Needs/Hospital Barn (SH) 
7) Maternity/Calf Barn (MC 7)     17) Parking Main Entrance (PM) 
 8) Maternity/Calf Barn (MC 8)      18) Parking/Employee/Showers (PS) 
9) Dry Cow/Transition Barn (DC)       19) Equipment Storage (ES) 
10) Solids Separator (SS)    20) Machine Storage Area (MS) 
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         General Discussion and Recommendations for Future Research 
    For most of the twentieth century, the predominant sentiment about the treatment, control, 
and prevention of infectious disease was optimism, both in human and animal health (4). For 
instance, in 1969, (then) Surgeon General William Stewart told the United States Congress 
that “it was time to close the book on infectious disease”(4). To be fair, there were many 
significant advances in disease control and prevention, including the development of 
antibiotics (termed “wonder drugs”) that increased human life expectancy-from 47 years in 
1900 to 68 years in 1950 (22). Public health measures such as protection of food and water 
supplies, improved nutrition, and personal hygiene also increased lifespan (22). Animal 
health also benefited from scientific advances. LeBlanc et al. (2006) noted that in the 1940s, 
antibiotics revolutionized the treatment of common animal diseases, and in the 1960s there 
was a shift from reactive medicine (treating illness) to proactive medicine (disease 
prevention) (21). However, the over-optimism and complacency of the 1960s was tempered 
with the reality of recently discovered disease (such as AIDS) and zoonotic diseases (22).For 
example,  Escherichia coli O157:H7 (first identified as a pathogen in 1982) causes severe 
diarrhea and hemolytic uremic syndrome in humans; the same organism is a cause of mastitis 
in dairy cattle (21, 25). Campylobacter jejuni (discovered in the 1970s), can result in severe 
diarrheal illness in humans and abortion in cattle (13, 29).  
    Antibiotics have become indispensable tools for decreasing morbidity and mortality 
associated with infectious diseases in humans and animals (24). Yet in the past 10-15 years, 
there has been rapid acceleration in the emergence of MDR pathogens including those of 
importance in food microbiology (28, 34). At the same time, there are also more individuals 
susceptible to disease (4). Aging, increases in underlying (typically immunosuppressive) 
diseases, and technological advances in health care are all factors (4). Additionally, there is 
currently little consensus on proper antibiotic use in a (including in a farm environment). 
There are those who believe that antibiotics are a vital part of the livestock industry (16) and 
antibiotics are important in treating diseases, increasing weight gain, and improving feed 
efficiency (14). Supporters concede that commercial livestock production in the United 
States, especially confinement production would be virtually impossible without antibiotic 
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drugs (23). The American Veterinary Medical Association (AVMA) opposes US 
Congressional legislation amending the Federal Food, Drug, and Cosmetic Act to eliminate 
the non-therapeutic use of antibiotic drugs considered important for human health (30). Non-
therapeutic use refers to “…use of a drug as a feed or water additive (in the absence of any 
clinical disease) for growth promotion, feed efficiency, weight gain, routine disease 
prevention or other purposes” (30). The AVMA has also cited their cooperation with the 
Centers for Disease Control and Prevention (CDC), the Food and Drug Administration 
(FDA) and others agencies to promote “prudent and careful therapeutic use of antimicrobials 
(24, 30). 
    Conversely, there are researchers that believe excess amounts of antibiotics are used; not 
only in human medicine and animal agriculture-but in numerous preparations (including 
cleaning products and over-the-counter preparations) (34). While the evidence is considered 
“complex” (Dryden et al. 2009), it is generally accepted that increased antibiotic use is 
associated with greater bacterial resistance (26). The American Society for Microbiology 
(ASM) Task Force on Antibiotic Resistance believes there is an urgent need for more prudent 
use of antibiotics in both human and veterinary medicine, especially as it relates to food 
production (24). Groups such as the World Health Organizations (WHO), the Institute of 
Medicine (IOM) of the National Academies and the Alliance of Prudent Use of Antibiotics 
(AUPA) have petitioned to discontinue the use of antimicrobial agents in food animals for 
growth promotion that are also used in human medicine (2). Several European countries (and 
the European Union) have taken steps toward banning certain antibacterial agents as growth 
promoters in farm animals (2). They cite studies in which the discontinuation of 
antimicrobial agents as growth promoters have resulted in a decrease in antibiotic resistance 
in animals, food products and humans (2).  
    There is also a growing consensus that alternative research is necessary in areas such as 
livestock production and veterinary/human medicine regarding antibiotic use. Possibilities 
include creating alternatives to antimicrobial growth promoters (16),  developing new 
antibiotics (11), improving disease control on farms (using methods such as epidemiology, 
nutrition, and improved design of animal housing) (21), improving human and veterinary 
diagnostic laboratories (24) and increasing the number of studies to decrease the 
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“information gaps” that exist in diverse areas such as microbial ecology, bacterial 
pathogenesis, and food safety (5, 21, 24, 27).  
  There is very little research regarding the (longitudinal) establishment and proliferation of 
bacterial organisms on a new dairy farm environment. Most studies focus on bacterial 
contamination of foods including ground beef and unpasteurized milk (12), eggs (9), fresh 
produce (1) and meat products (17). The studies on environmental contamination tend to 
focus on areas such as the survival of zoonotic pathogens in soil, water and animal excrement 
(manure) (3). When assessing the research that took place on the ISU Dairy farm there was 
one important conclusion that applied to all collected data. Temperature and humidity did not 
affect the proliferation of bacterial organisms (also referred to “seasonality” in some 
literature) (15). The length of time that dairy cattle resided on the farm was more of a factor 
(even though there were circumstances when the number of CFUs of bacteria would 
repeatedly increase and decrease; one example of this can be found in the Enterococcus 10-3 
and 10-5 data, tables 4-9).  
    When reviewing the Enterococcus data, it was noted that antibiotic resistance colonies 
grew on TSA plates with very high levels of antibiotics (48 ug/mL of ampicillin, 48 ug/mL 
erythromycin, and 24 ug/mL tetracycline). The antibiotic concentration was much higher 
than recommended by the Clinical and Laboratory Standards Institute (CLSI). This is 
significant because of the increasing difficulty of treating enterococcal infections due to 
multidrug resistance (10, 20) Additionally,  vancomycin (considered the “last line of 
defense” in the treatment of Enterococcus) is becoming less effective, resulting in increased 
mortality and morbidity of human patients (18). In terms of establishment and proliferation 
of enterococci, it became evident that the placement of dairy cattle directly correlated with 
establishment and proliferation. In tables 4-9 of the Enterococcus data, low levels of CFUs 
(or no CFUs) were recovered prior to dairy cow introduction. After dairy cow introduction, 
the numbers of CFUs dramatically increased-except for ampicillin (table 7). Again, it is 
notable the number of CFUs were cyclic in nature.  
    Since there were substantial amounts of data collected while studying Campylobacter, four 
locations were reviewed in detail; the maternity and calf barn, solids separator, free stall barn 
and the special needs/hospital barn. Antibiotic resistance was not detected prior to dairy 
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cattle introduction. After placement of dairy cattle, there were increases in the numbers of 
CFUs as well as resistance to a single drug/multidrug resistance (tables 3, 6 and 7 of 
Campylobacter data). The Tryptic Soy Agar (TSA) plates were made with higher 
concentrations of antibiotic recommended by CLSI. Additionally, with the progression of 
time, multidrug resistance was detected throughout the farm environment. Location was not a 
significant factor; multidrug resistance was eventually detected throughout the farm 
(Campylobacter data, tables 6 and 7). There was some fluctuation in the presence of 
antibiotic resistance-which also occurred in other Campylobacter studies (7, 8). 
    When evaluating data from the Enteorbacteriaceae experiments (table 4 of 
Enterobacteriaceae/Salmonella data), it appears likely that the introduction of dairy cattle 
was directly related to changes in the genera and species of Gram-negative bacteria present. 
The types of recovered organisms changed from those that rarely cause zoonotic disease to 
those causing disease-some which are of concern due to increasing antibiotic resistance. 
Recovery of Salmonella on XLT-4 media was minimal (plating of environmental samples 
directly from serial dilutions to XLT-4 media; table 6 Enterobacteriaceae/Salmonella data). 
Typically there are enrichment steps that are followed when detecting Salmonella on 
specialized media; for that reason, it may take 4-7 days to recover organisms (32).  The BAX 
PCR System ™ is more sensitive than conventional plating method. In table 6 
(Enterobacteriaceae/Salmonella data), there were only 3 locations that were Salmonella 
positive using XLT-4 (with no enrichment); F10 (the solids separator); F13 (the free stall 
walkway); and F16, (the special needs/hospital barn). However, BAX PCR detected 43 
environmental locations that were Salmonella-positive (figure 1 
Enterobacteriaceae/Salmonella data). Additional Salmonella-positive data (table 5) were 
derived by enrichment on specialized media (listed on table 3 of 
Enterobacteriaceae/Salmonella data). All Salmonella-positive plating results were sent to the 
NVSL for confirmatory serotyping. 
    Two serotypes of Salmonella were detected during the study; S. montevideo (3 isolates) 
and S. london (17 isolates).  The presence of S. london was initially detected in location D11 
(the free stall barn) after placement of dairy cattle and continued to be recovered until the 
conclusion of the study (table 5 Enterobacteriaceae/Salmonella data). Until recently, 
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presence of  S. london was restricted to far eastern countries such as Korea but is now 
beginning to appear worldwide (33, 36, 37). Researchers have advocated for additional work 
with S. london due to varying (but increasing) resistance to antimicrobials (36), the severe 
illness that can be caused by this serotype  (19) and its uncertain etiology (the study of 
causation or origination). The PFGE patterns of S. London from this study were clustered 
into two distinct groups. Most of the isolates from the first group were collected on 23 April 
2008 (G) and the majority of the isolates from the second group were collected on 12 March 
2008 (E). Despite the two groups, all of the isolates may be clonal in origin. Even though the 
BioNumerics program divided the isolates into two groups, some suggest that isolates with 
such minor profile differences (figure 3 Enterobacteriaceae/Salmonella data) are actually 
clonally related (of common origin) (6, 35). As mentioned, the etiology is uncertain although 
it is probable that the source of the isolates on the ISU Dairy Farm were cattle-given the 
(limited) evidence where milk products have been implicated in past S. london infections (19, 
31). It is uncertain if the isolates came from one animal or from multiple animals. 
    There is very little research regarding the establishment and proliferation of bacterial 
organism in a new dairy farm environment. Future research could include continued studies 
at the ISU Dairy Farm regarding the establishment of bacteria of interest in food safety (e.g. 
Salmonella, Campylobacter and Enterococcus) and antibiotic resistance. Baseline 
information (collected from this study) is now known. Additional antibiotics could be added 
(incorporated into TSA media)-especially antibiotics important in human and animal health 
(such as vancomycin in humans and Excenel/cephalosporin in cattle). Other tests involving 
antibiotic resistance-such as agar disc diffusion and broth microdilution-can ease the 
preparation time and expense of future studies. Individual dairy cows could also be followed 
to ascertain what types of bacteria are being shed in the farm environment. Certain categories 
of animals could be studied at length such as sick animals, animals that may be stressed 
(from calving), and new animals. Molecular studies should continue with S. london, since it 
is apparent that it may be an emerging serotype (36) . It is hoped that studies such as this 
could give additional insight into topics involving dairy cattle production and food safety. 
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1) Feed Storage Area (FSA)    11) Free Stall Barn (FS11) 
2) Open Field NE (OF)        12) Free Stall Barn (FS12) 
3) Heifer Barn 9-15 months (H9)       13) Free Stall Barn Walkway (FW) 
4) Heifer Barn 2-8 months (H2)      14) Holding Area Walkway (HW) 
5) Heifer Barn 16-22 months (H16)      15) Holding Area/Milking (HM) 
6) Maternity/Calf Barn (MC 6)       16) Special Needs/Hospital Barn (SH) 
7) Maternity/Calf Barn (MC 7)     17) Parking Main Entrance (PM) 
 8) Maternity/Calf Barn (MC 8)      18) Parking/Employee/Showers (PS) 
9) Dry Cow/Transition Barn (DC)       19) Equipment Storage (ES) 
10) Solids Separator (SS)    20) Machine Storage Area (MS) 
 
 
 
 
 
 
 
 
 
 
 102
Acknowledgements 
 
     I would like to thank everyone who has been helpful with my research as well as my 
friends and family who have been so supportive in my “long journey”. First, I want to thank 
my committee members-Jim Dickson (my major professor), Dennis Bazylinski (who for a 
time acted as my co-major professor), Aubrey Mendonca, Greg Phillips, Chuck Thoen and 
George Jackson (now retired). They had very high expectations-but I quickly understood that 
they wanted me to be successful. Dennis Bazylinski was especially encouraging when 
situations became challenging-sometimes I would laugh out loud at his “dry” (yet accurate) 
assessment of situations. I would also like to thank the faculty and staff in the Microbiology 
program (especially Ann Hetland and Simi Venkatagiri), as well as the graduate students-
some will continue to be my friends for life. 
    I also want to mention the Ecology, Evolution and Organisimal Biology (EEOB) faculty 
and staff-in particular, Jonathan Wendel, Dean Adams, Lynn Clark, John Downing, Fred 
Janzen, Deb Lewis, and Eve Wurtele. They were extremely kind during the most difficult 
circumstances. The EEOB secretarial staff (Paula Sandlin, Joanne Nystrom, and Joyce 
Hansen) worked hard to keep me here at ISU. They were very strong advocates during the 
illness and death of Bob Andrews, my former Ph.D. advisor and I’m very grateful. Speaking 
of Bob Andrews, I still feel that I was lucky (and blessed) to have worked for him.  
    The Dairy Science staff was extremely helpful. They allowed me to work-but also kept a 
respectful distance to make sure that I didn’t get hurt or killed while sampling. The staff 
manages an exceptional facility. Many thanks to Leo Timms, Joe Detrick, and Bruce 
Leuschen. I also want to thank the graduate students in the Meat Science program; they 
gently laughed at the antics of a “city girl”-and later taught me how to do things totally 
unrelated to my program of study-such as make processed meat products (thanks, Armitra 
Jackson, Kohl Schrader, and Dr. Joe Sebranek). I am also grateful to Kay Christiansen for 
being instrumental in media preparation and lab organization. When I started to feel sorry for 
myself (for example, when I was sprayed by the solids separator), she told me with a laugh to 
“suck it up and keep working”. Well said, Kay! We even made up our own name for the 
solids separator-which can not be repeated here. Thank you for your professionalism and 
kindness. 
 103
     I owe so much to the Dickson Lab staff-in particular Jim Dickson and Steve Niebuhr. Dr. 
Dickson is very knowledgeable, well regarded-and unpretentious. I want to thank him for his 
mentoring, gentle pushing (when needed) and support through the years. I am very 
appreciative of what he has done for me professionally and personally. Steve Niebuhr is a 
wonderful lab manager. He keeps the undergrads, grad students, and the Dickson lab research 
projects well-organized. As we often say in the lab, “Steve is soooooo patient”… The 
Dickson lab group gets along extremely well-and Steve and Dr. Dickson are the main reasons 
why. Also, the Dickson lab undergrads are the most energetic and intelligent people… 
especially when working on a project at 6:30 AM! The grad students were half-asleep during 
that time (especially when spending the previous night studying for prelims). I wish everyone 
in the Dickson lab group much academic and personal success. 
     Lastly, I would like to thank my friends and family. My friends have been so wonderful 
and I can only hope that I’m the same to them. My family has been the “rock” of my life-and 
I couldn’t have done it without them. I would like to thank Opal Vaughn and Dr. Ron 
Blackmon for being my “guardian angles”. G. Louise Ware has been an excellent mentor and 
I appreciate her advice. My parents, Don and Phyllis Butler are wonderful and have spent a 
lot of time (and money) for me to get to this point. Thank you for being very supportive. My 
sister, Kim and her family continue to shower me with love-sometimes when I’m not so 
lovable. In conclusion, my “spiritual family” at Corinthian Baptist Church has been very 
instrumental in reminding me about what is truly important. I appreciate that they continue to 
train me in the “way that I should go”.  
 
 
 
 
 
 
 
 
